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Since previous results in this laboratory had indicated that
vitamin E was necessary in vivo not only for the optimal sulfation
of mucopolysaccharides, but also for the oxidation of neutral sulfur
to sulfate, the ability of whole liver homogenates from vitamin Esufficient and -deficient rats to convert cysteine to sulfate was investigated.

Then an attempt was made to determine the specific site

of the decreased oxidation of cysteine or its intermediate oxidation
products.

Since several alternative pathways have been proposed in

animals for the ultimate oxidation of the sulfur of cysteine to sulfate
and the use of the sulfate formed, it was necessary to limit this investigation to the most widely accepted pathway, that of the oxidation
of cysteine to sulfate through cysteinesulfinic acid and sulfite.

Low

sulfate diets were employed to force the animals to satisfy their inorganic sulfate needs by the oxidation of the sulfur amino acids.
A statistically significant decrease in the conversion of

35

s-

cysteine to 35s-sulfate was found in whole liver homogenates from the

Form G-20

2

vitamin E-deficient male, but not the female, rats fed the low sulfate
diets when these were compared to their littermate controls.

When male

and female rats fed normal sulfate vitamin E-sufficients diets were
compared, there was no statistically significant difference in the
35
.
.
conversion
o f 35S-cyste1.ne
to
S-sulfate.

There was a statistically

significant decrease in the ability of mitochondrial homogenates from
the vitamin E-deficient "prepped" female rats to convert
to

35

S-cysteine

35
S-sulfate when these were compared with their littermate controls.

No difference could be detected in the ability of acetone powder
extracts from vitamin E-deficient and -sufficient male rats to oxidize
sulfite to sulfate, as indicated by ferricyanide reduction.

Tests were

made to determine the presence of cysteinesulfinic acid and sulfite after
incubation of cysteine with denucleated homogenates, but neither substance could be detected.

The conversion of cysteine to a ninhydrin-

positive material thought to be cysteinesulfinic acid by supernatant
preparations of liver from vitamin E-deficient and -sufficient male and
female rats was also studied in the presence of an inhibitor.

There

was no detectable difference in the ability of these preparations to
oxidize cysteine.

A mechanism is proposed for the involvement of ATP in the oxidation of the sulfur group of cysteine to sulfate, since ATP, as well
as vitamin E, is implicated in this conversion by results found during
the course of this research.
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CHAPTER I
INTRODUCTION
Many of the in vivo and in vitro functions of vitamin E can be
influenced by selenium, the sulfur amino acids, other antioxidants, or
prooxidants.

Whether the entire function of vitamin Eis that of an

antioxidant is still the subject of some debate, but there are increasing reports of other biochemical and physiological functions for the
vitamin.

Many of the changes involved in a deficiency of the vitamin

have been attributed to lipid peroxidation, but there is a growing
indication that peroxidation may be only a result of a far more complicated process.
A previous report from this laboratory has shown a decreased
fixation of injected 35 so 4 = by the mucopolysaccharides of vitamin Edeficient rats maintained on a typical, with respect to inorganic sulfur,
diet.

However, the combination of a drastic restriction of the dietary

inorganic sulfur with avitaminosis E resulted in a stimulatory effect
on sulfate fixation by cartilage, a decrease in the per cent sulfur in
the cellular lipoproteins, and an increase in the blood sulfhydryl level.
These results were interpreted as an indication that vitamin E was
necessary not only for the optimal sulfation of mucopolysaccharides, but
also for the oxidation of neutral sulfur to sulfate (1).
1

2

Because of the in vivo effect of vitamin E deficiency on the metabolism of sulfur, a study of the in vitro oxidation of cysteine to sulfate
was undertaken to try to determine the site of the decreased production
of sulfate.

Since several alternative pathways have been proposed in

animals for the ultimate oxidation of the sulfur of cysteine to sulfate
and the use of the sulfate formed, it was necessary to limit this investigation to the most widely accepted pathway, that of the oxidation of
cysteine to sulfate through cysteinesulfinic acid and sulfite.

CAAPIBR II
REVIEW OF THE LITERATURE
I.

VITAMIN E

The primary activities in which a vitamin may engage are that
the vitamin is a part of an enzyme molecule or that it cooperates within an enzymic reaction.

A secondary activity is that the vitamin pre-

serves another vitamin or enzyme against destruction by some toxic
agent.

It may replace or be replaced by another vitamin or anti-

vitamin.

The requirement for the vitamin may be altered by nutritional

factors not themselves vitamins (2).
Vitamin E definitely has a role as an antioxidant, but its role
also seems more specific (3).

a-Tocopherol is probably a cofactor in

the synthesis of ascorbic acid and may be concerned with the biogenesis
of ubiquinone or may function in connection with its similarity to
ubiquinone U(SO) (4, 5).

a-Tocopherol or a metabolite is necessary

for the maintenance of a-ketoglutarate and succinate oxidation by liver
homogenates (4).

The specific structure of vitamin E may be to increase

the fat solubility of the vitamin or to adapt it to function as a
coenzyme (6).

Metabolites of Vitamin E
To understand the role of a-tocopherol one needs to isolate,
separate, and identify the metabolites (7).
3

There is still some

4

disagreement as to what these metabolites are.

Incubation of tocopherol

with rat liver homogenates under conditions which have been shown to
prevent an in vitro metabolic lesion did not lead to the formation of
new active metabolites of the vitamin.

Other than appearing to be

bound to the protein, a-tocopherol seemed to be its own active metabolite
in the in vitro system (8).
The interconversions of a-tocopherol and its oxidation products
have been discussed (Figure 1).

a-Tocopheroxide was active but less

potent than a-tocopherol in rat fertility.

a-Tocopherylquinone and

a-tocopherylhydroquinone were inactive in high doses, but both were
active if given frequently (9, 10).

a-Tocopherylhydroquinone disuccinate

was active against dystrophy in rats but was not active against
sterility (11).

Nutritional muscular dystrophy in the rabbit could be

prevented or cured by a-tocopherylquinone, a-tocopherylhydroquinone, or
a-tocopheroxide, as well as by a-tocopherol (9).

Some vitamin E com-

pounds helped reverse respiratory decline when injected into the
animal (12).
Selenium and vitamin E increased ubiquinone in heart, kidney,
and liver, but only vitamin E increased the level in the uterus of the
rat (13).

Pantothenic acid deficiency also increased liver ubiquinone.

Vitamin A deficiency had no effect on ubiquinone or ubichromenol except
in the liver, but vitamin E deficiency depressed ubiquinone levels in
thirteen tissues and ubichromenol in most tissues.

With vitamin E

supplementation after a deficiency, ubiquinone increased while ubichrom-
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a-Tocopherylquinone

Interconversions of tocopherol metabolites (9).

V,
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enol decreasedo

Sodium selenite, when added to a vitamin E-deficient

diet, increased ubiquinone in the liver.

The level of ubiquinone was

higher in the female than in the male and varied with the age of the
animal (14).

DPPD (N,N'-diphenyl-2-phenylenediamine) and Santaquin

had no effect on ubiquinone or ubichromenol levels.

These results

suggest no antioxidant or protective effect for vitamin E under these
conditions (15).
The chromanol of hexahydrocoenzyme Q4 prevented encephalornalacia
in the chick, resorption in the rat, and cured muscular dystrophy in the
rabbit.

The chromanal of vitamin K1(20) also protected against encephalo-

malacia in the chick (16).
a-Tocopherol maintained a high level of ubiquinone in rat tissues.
A large dose of a-tocopherol elevated ubiquinone in the heart without
elevating tocopherol.
concentrations.

Tocopherylquinone also increased ubiquinone

These data provided further evidence that the main

biological function of tocopherol is unrelated to its lipid antioxidant
property.
metabolite.

Simon's quinone was checked to see if it was a tocopherol
It caused a greater and more rapid increase in ubiquinone

concentration on a molar basis that a-tocopherol.

This water soluble

metabolite of vitamin E was suggested as the active biological form.
The lactone form of Simon's quinone perhaps should be called tocopheronolactone and the acid form, the tocopheronic acid (17).

7

The tocopheronolactone increased ubiquinone and protected in vitro
against lipid peroxidation in the vitamin E-deficient rat liver homogenate.

It also prevented respiratory decline and restored oxidation of

a-ketoglutarate.

The biochemical role may be in oxidation-reduction.

A soluble enzyme was found that coupled the reduction of tocopheronolactone to the oxidation of reduced pyridine nucleotides (18).
It has also been said that a-tocopherol is neither a precursor
of ubiquinone nor necessary for the biosynthesis of ubiquinone (19) and
that there is no evidence for a metabolic role of vitamin A in ubiquinone
synthesis (20), but the tissue levels of ubiquinone and tocopherol in
birds tend to support the concept that there is a relationship between
tocopherol, ubiquinone, and oxidative processes in animals (21).
a-Tocopherol phosphate lowered the oxygen consumption of dystrophic rabbit muscle to normal in a short time.
returned to normal.

The creatine levels

a-Tocopherol phosphate decreased the high succin-

oxidase activity in vitamin E-deficient hamster muscle (22).

The oxygen

uptake of dystrophic rabbit muscle was reduced in less than ten hours
after the administration of a-tocopherol acetate (23).
ester of a-tocopherol inhibited most enzymes (24).

The phosphate

The administration

of a-tocopheryl phosphate to rats led to muscular weakness, depression
of basal oxygen consumption, and depression of endogenous respiration
in skeletal muscle.
be impaired (25).

This suggested that glycogen phosphorolysis might
A mechanism for the possible formation of ATP (adeno-

sine triphosphate) by oxidation of substituted hydroquinones is given in
Figure 2 (26).
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Figure 2. Possible formation of ATP by oxidation of substituted
hydroquinones (26).
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The main source of energy for the synthesis of high energy phosphate is coupled with oxidation in the electron transport system.

Ubi-

quinone is known to be an essential component of the electron transport
chain and is probably concerned with the flow of electrons from substrate to the cytochromes (4).
Interrelationships Between Vitamin E and Other Factors

Ascorbic acid.

Ascorbic acid in diets low in vitamin E delayed

the onset of dystrophy in rabbits.

Ascorbic acid synthesis seemed to

depend on coenzymic factors altered by a deficiency of vitamin E.

Con-

trol and deficient animals showed no difference in the destruction of
vitamin C by enzyme preparations (27).

The inhibitor produced by gulo-

nolactone oxidase in the presence of its substrate accelerated the decay
of succinate oxidation in mitochondria from vitamin E-deficient animals
(28).

Nucleic acid, nitrogen, and phosphorus metabolism.

The relation-

ship of vitamin E to nucleic acid, nitrogen, and phosphorus metabolism
has been investigated.

Vitamin E-deficient rabbits excreted large

quantities of allantoin compared to control rabbits.

This suggested

deranged nucleic acid metabolism, which could be either accelerated
turnover of nucleic acids or accelerated purine synthesis with failure
to incorporate the product formed.

Because of the increased rate of

incorporation of formate into tissue nucleic acids, vitamin E was thought

10

to regulate the turnover of nucleic acids (29).

Since vitamin E

deficiency did not significantly influence the oxidation of formate
to carbon dioxide in monkeys and since there was increased incorporation of formate into tissue nucleic acids in skeletal muscle and bone
marrow in vitamin E deficiency, the conclusion was that this deficiency
affected mainly DNA (deoxyribonucleic acid).
affected (30).

Other tissues were un-

Vitamin E deficiency in rabbits led to an increase in

the incorporation of

32

P into tissue nucleic acids (31).

The DNA per

gram of liver, coenzyme A, ATP, and ADP (adenosine diphosphate) levels
increased when additional vitamin E was fed to rats (32).
In vitamin E deficiency in rabbits phosphate left the serum and
entered the muscle cell faster than in normal rabbits, but it was not
incorporated into organic phosphorus compounds so well.

When the

utilization of creatine phosphate by muscle extracts from vitamin Edeficient rabbits was investigated, there seemed to be a specific impairment of the system that phosphorylated creatine; however, tocopherol
was doubted as a cofactor (33).

Dystrophy; increased urinary creatine,

allantoin, and free amino acids; decreased urinary creatinine; anemia;
and granulocytosis are symptoms of vitamin E deficiency in the monkey
(34).

The specific activity of plasma inorganic phosphate was unchanged
in vitamin E deficiency and decreased in hyperthyroidism.

The skeletal

muscle inorganic phosphate specific activity was increased in vitamin E
deficiency.

The specific activity of creatine phosphate and ATP was
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high in vitamin E-deficient rabbits and hyperthyroid rats.

This indi-

cated an elevated turnover of skeletal muscle intracellular inorganic
phosphate and a normal or decreased turnover of skeletal muscle creatine
phosphate and ATP in vitamin E deficiency.

There was no decrease in

creatine phosphate or ATP in hyperthyroid rats.

Hyperthyroidism may

affect mitochondrial membranes (35).
The creatine pool would increase in vitamin E deficiency in the
rat because the uptake of creatine by muscle decreased.

This decreased

uptake would account for the lowered creatine content of the muscle and
the lowered creatinine excretion.

There may be a defect in the creatine

transport across the cell membrane (36).
Pyridoxine deprivation hastened the appearance of dystrophy when
vitamin E was absent in the rat (34).

Rats deficient in both vitamin E

and vitamin B 6 had increased excretion of allantoin and creatine, and
adding either vitamin prevented this increase.

Vitamin B 6 deficiency,

but not vitamin E deficiency, decreased growth and excretion of xanthurenic acid after a tryptophan load (37).
Decreased phosphorylase activity in vitamin E-deficient chicks
has been reported (38).

The increase in total muscle phosphorus in the

dystrophic chick was due to an increase in the inorganic phosphate
fraction, while ATP and creatine phosphate decreased.

There was greater

permeability of phosphorus, potassium, and cesium and an increased
potassium turnover in the dystrophic chick muscles than in the control
(39).

This indicated phosphorus metabolism might be specifically

affected during vitamin E deficiency in the chick (40).
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The free amino acids in muscle extracts from vitamin E-deficient
rabbits were elevated when compared to normal rabbits.
in the deficient animal was decreased (41, 42).

The muscle glycine

Taurine decreased in

the muscle of the vitamin E-deficient rabbit and climbed slightly or did
not change in the other tissues checked (42).
A deficiency of vitamin E increased the recovery of respiratory
14c from injected 1- 14c-glycine, 1- 14c-leucine, and l- 14c-lysine in the
rabbit.

Avitaminosis E, uncomplicated by inanition, had no effect on

the oxidation of glucose or palmitate.

The rate of oxidation of amino

acids seemed to be increased in vitamin E-deficiency (43).

The specific

activity of protein increased in vitamin E-deficient rabbits, when compared to controls, after administration of

14
c-glycine.

The specific

activity of methionine was also increased after administration of
14c-forrnate on the basis of protein content, but formate incorporation
was increased only on a µmole basis.

Removal of formate for synthesis

of the creatine and allantoin lost in excess would account for the
increased specific activity of the compounds requiring I-carbon fragments (44).
An increase in the glutathione content in the liver and muscle
of rabbits with avitaminosis E has been reported (45).

Erythrocyte

glutathione was slightly elevated, and glycine was incorporated into
the glutathione of muscles at an increased rate.

The metabolism of

glutathione in tissues of rabbits was felt to be, to some degree, controlled by vitamin E (46).
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Since glutathione might play an important part in the maintenance
of the integrity of the structure and function of the erythrocyte and,
perhaps, of all tissue cells (47), the glutathione content of erythrocytes from tocopherol-deficient and tocopherol-supplemented rats was
measured and compared to the extent of hemolysis by various compounds.
There was no difference in the glutathione content of the red blood cells
of the supplemented and deficient animals.

Hemolysis was independent

of glutathione content when the cells were exposed to oxygen, selenite,
or heavy metal sulfhydryl reagents.

Susceptibility to hemolysis in the

vitamin E-deficient animal was found not to be related to any alteration
in the glutathione concentration (48).

Hemolysis of erthyrocytes.

Rat blood cells were hemolyzed in the

presence of hydrogen peroxide even when the animals were fed stock diet
or rations containing vitamin E, but cells from the vitamin E-deficient
rats were hemolyzed to a greater extent than those from vitamin E-sufficient animals.

Catalase should prevent hemolysis if hydrogen peroxide

production were the basic cause for hemolysis by dialuric acido

The more

rapid hemolysis with dialuric acid than with hydrogen peroxide and the
lower concentration required suggested that hydrogen peroxide per se was
not the hemolyzing agent (49).
Hydrogen peroxide-induced hemolysis of red blood cel~s from vitamin
E-deficient rats is said to be closely associated with lipid peroxidation
of the cell stroma (SO).

However, red blood cells from tocopherol-defi-

cient rats did not have increased levels of lipid peroxides until after
treatment with an oxidizing agent.

Therefore, there was no evidence for

14
alteration in the red cell membrane in avitaminosis E (Sl)o

Large oral

doses of methylene blue had no effect on the prevention~ hemolysis
(52, 53)o

Thyroxine, co+2, Mn+ 2 , Cr 2 o 7 =, and Cro 4 = protected in vitro

against hemolysis and peroxidationo

Hemoglobin, Fe+3, ascorbic acid,

cysteine, glutathione, and selenite increased hemolysis of red blood
cells from vitamin E-deficient animals (54, 55)o

Attempts have been

made to explain the mechanism of hemolysis (56).

Susceptibility of

erythrocytes to hemolysis is also an indication of vitamin E deficiency
in chicks (57, 58).
Hemolysis of rat erythrocytes by dialuric acid could be prevented
by Oo4 mg. of DL-a-tocopherol per kg. of body weight per dayo

Several

times this dose of the vitamin were required to prevent sterility and
dystrophy (59)o

Males required 3o5 mg. of vitamin E per kg. per day

and females only 2.5 mg. per kg. per day (60).
Dialuric acid hemolysis in the premature infant was not effective
in evaluating the vitamin E status (61).

Vitamin E was effective in

vivo or in vitro for the prevention of hydrogen peroxide-induced hemolysis, but administration of the vitamin to the mother before delivery
was not effective (62).

In the adult recovery from the susceptibility

of erythrocytes to hemolysis required a long time after resupplementation with the vitamin (63).
Cystic fibrosis could make man appear to have nutritional
muscular dystrophy (64).

This condition was induced because of the

poor absorption of tocopherol (65).

In normal adults 7 per cent of

the people studied had blood tocopherol values that were considered

15
too low.

The cause could be either low intake of vitamin E or high in-

take of unsaturated fatty acids (66).

There also seemed to be a rela-

tionship between sex and blood tocopherol levels in man (67).

The

tocopherol requirement was a function of the amounts of certain peroxidizable lipids in the diet and tissues.

Linoleic acid appeared to be

the most significant oxidizable lipid in the diet, but other unsaturated
fatty acids might also be important.

When the peroxidizable fatty acids

were low, the tocopherol need decreased.

The peroxide hemolysis test

was felt to indicate only the rate at which erythrocyte fatty acids
could be oxidized (68).

Erythrocyte survival.

In vivo hemolysis after vitamin K admin-

istration to vitamin E-deficient animals suggested that the vitamin .E
status might have a bearing on the in vivo red cell survival in certain
circumstances (69).

The survival of erythrocytes from monkeys and rats

was shortened in vitamin E deficiency (70, 71).

The vitamin may be

considered a hernatopoietic agent in monke~fs and in malnourished human
infants with macrocytic anemia (72).
Growth in the rat.

Vitamin E h&s some effect on growth in rats.

The females responded less, if at all, to lack of vitamin E.
decreased in growth on the vitamin E-deficient diet (73).

The males

The failure

in growth due to vitamin E deficiency was characterized only in the last
phase, that after attainment of maturity, normally viewed as a plateau
in the growth curve, although all animals showed a slow ascent.

The
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plateau occurred after about 100 days of life.
more than adequate protein (74).

These diets contained

Increased growth when vitamin E was

added to an otherwise adequate diet lacking in the vitamin has also
been observed (75).

On the other hand, vitamin Eis reported to have

an effect on growth only when the protein level is below 10 per cent
(76).

The tocopherol requirement for growth in the rat could be related

to dietary or tissue lipid fatty acids when methionine and the environment were optimal.

If the vitamin E level in the diet was low, growth

could be related to the level of selenium (77).

The adult rat suffer-

ing from chronic avitaminosis E developed paresis after the nineteenth
experimental week (77).
Reproduction in the rat.

There has been some disagreement about

the absolute necessity of vitamin E for the prevention of sterility in
the rat.

DPPD replaced vitamin E in the prevention of sterility in

females in some studies (79).

This antioxidant was toxic, and the

amount needed to prevent stillbirths was only slightly below the toxic
level (80).

The role of vitamin E could, therefore, be only in the

preservation of a non-vitamin E compound (81).
vent resorption-gestation in the rat.

Factor 3 did not pre-

Vitamin free casein is generally

a good source of Factor 3 (82).
If the vitamin E-deficient female rat received supplementary
vitamin E before the eighth day of gestation, the pups were normal.
Supplementation between the ninth and twelfth day resulted in deformed
young.

If supplementation was delayed until after the twelfth day,
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resorption of the fetuses occurred (83).

Other conditions in the rat.

Other symptoms of vitamin E defi-

ciency in the rat are a brownish discoloration of adipose tissue, depigmentation of incisor enamel, and renal histolysis.

The yellow-brown

discoloration of adipose tissue depended on the presence of dietary codliver oil and the depigmentation of the incisor enamel upon the dietary
fats (84).

If 0.9 p.p.m. selenium was fed to rats whose teeth were

white from a vitamin E-deficient diet, the pigment returned to the
teeth, but growth was retarded.

A lower level of selenium reversed the

tooth depigmentation only temporarily (85).

Dietary fat and vitamin E

influenced renal histolysis, with the time elapsed between death of the
animal and examination of the kidney also having some effect (86, 87).
This phenomenon may be related to an altered state of unsaturated fatty
acid incorporation into phospholipids and lipoproteins of membranes (87).
Methylene blue, an antioxidant, has been found to delay incisor depigmentation and prevent uterine pigmentation, but its effect on the prevention of sterility and erythrocyte hemolysis is in doubt.

It also

increased the vitamin A stored in the rat (88).
The testes of the vitamin E-deficient rat have increased proportions

of 18:26J6, 20:46J6, and 22:46.16 fatty acids and decreased amounts

of 22:5lJ6, but no change in 20:3~6.

This suggested that inhibition

in the conversion of 20:4 to 22:5 fatty acids occurred (89).
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Sulfur and selenium metabolism and peroxidation.

Tocopherol acts

in some way to maintain the proper functioning of enzyme sulfhydryl
groups (90).

The protective effect could be by oxidation-reduction

reactions of the quinone with sulfhydryl groups at the active sites,
which would force equi~ibrium to the disulfide form, thus inhibiting
the point of attack by heavy metals.
by Fe+3.

Reduced tocopherol is reoxidized

A vitamin E metabolite might serve as an intermediate carrier

for electron transfer from reduced mono- or dithiol sites of enzymes
or as a cofactor to the iron-containing catalysts.

Or the quinoid

structure might react with the sulfhydryl groups by condensation.
Tocopherol metabolites might have a shielding effect on labile sulfhydryl
groups because of this.

These products could be the real electron

transfer configurations and should be sensitive to heavy metals (91).
Loss of free sulfhydryl groups occurs concurrently with oxidative
decline (90).

There has been a suggestion that protein carriers are

involved in the transport of vitamin E in the blood (69).
The term
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antioxidant" designates compounds which quench electron

mobility, scavenge free radicals, break free radical chain reactions,
or chelate trace metals (92).

Vitamin Eis an antioxidant.

Sulfur

amino acids could also act as antioxidants somewhat similar to vitamin
Eby reacting with free radical intermediates of lipid peroxidation,
thereby breaking the chain reaction 1 or by decomposing lipid peroxides.
Cysteine

1

glutathione, and sulfhydryl proteins are a large and reactive

pool of redox compounds for reduction of vitamin E.

If free radical
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lipid peroxidation did proceed, the sulfur amino acids would protect
cellular constitutents.
the damage (93)o

Further, the amino acids could react to repair

The soluble thiols in the aqueous phase and vitamin

E in the lipid phase might inactivate damaging free radicals.

The

cerebella in chicks with encephalomalacia showed damage expected from
formation of free radicals (94).

A scheme for the relationship between

lipid peroxidation, vitamin E} ascorbic acid, and sulfhydryl compounds
was proposed (Figure 3) (93).
Vitamin E and selenium may act independently in alternative pathways of energy metabolism and both pathways would have to be impaired
before illness occurred (95).

Selenium will not prevent all aspects of

vitamin E deficiency in animals.
some cellular component.

It is apparently incorporated into

Since a general rule should apply to a variety

of species, vitamin E and selenium cannot act exclusively as antioxidants because rat and guinea pig tissue do not respond to both in the
same way (96).

There are several other objections to interpreting the

biological activity of selenium in terms of an antioxidant.

Sulfur

compounds with antioxidant properties are present in much greater concentrations than any selenium compounds.
been proposed to be a selenium amino acid.

The selenium antioxidant has
However, the amount of

selenium in the tissues is much greater than can be accounted for by
known selenium amino acids.

Inhibition of lipid peroxidation with

selenium reaches a maximum (77).

Dehydro
Ascorbic
Acid

Unsaturated
Lipid
Radical

NADP
Cysteine,
Glutathione,
RSH

Glutathione

Unsaturated
Lipid

Tocopherol
Radical

Cystine,
Oxidized glutathione
R-S-S-R
Ascorbic
Acid

NADPH

Figure 3. A possible relationship among lipid peroxidation, tocopherol, ascorbic
acid, sulfhydryl compounds, and NAD (93).

N
0
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Three factors, cystine

1

vitamin E, and Factor 3 (selenium), separ-

ately protected livers from necrosis.
cysteine (98).

Cystine was more effective than

The development of liver necrosis depended on the com-

position of the diet, the endocrine status, the daily food allowance,
and the environmental temperature (99).

Methionine and cysteine could

not replace selenium as one of the three factors preventing necrosis if
they did not contain traces of selenium (100).
so affected by a necrogenic diet as the male.

The female rat was not
Thyroid removal served

to prevent necrosis, possibly through its adverse effect on appetite
(101).

Liability to necrosis decreased with age (102).

Diets adequate

in protein protected against liver necrosis (103).
Increased cystine in the diet protected against necrosis in rats,
but not against hernolysis (104).

The potency of cystine is largely due

to contamination with Factor 3 (105).

A contamination in sulfur corn-

pounds of one selenium atom for 350,000 sulfur atoms per 100 g. of diet
would be sufficient to prevent necrosis (106).

Factor 3 is water soluble

and stable to acid hydrolysis (107).
The latent phase of necrotic liver degeneration is characterized
by respiratory decline in homogenates from rat liver (108).

In rats

fed Torula yeast and deficient in vitamin E and Factor 3 respiratory
decline occurred 1-2 weeks before liver degeneration.

Added vitamin E

completely prevented the decline, while additional amounts of Factor 3
and selenite only helped prevent this decline.

A tocopherol metabolite

and DPPD prevented in vitro respiratory failure of rat liver slices.
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Fresh homogenate had to be used because aging for several hours would
nullify the protective effect of tocopherol (109).
The decline in rate of oxidation with incubation time differed
depending on substrate employed, its concentration, and whether or not
vitamin E was present in the diet.

The concentration of a-ketoglutarate,

~-hydroxybutyrate, pyruvate, and malate affected the vitamin E-deficient
homogenates differently from the controls with respect to respiratory
decline.

There was no difference in decline between the vitamin E-

sufficient and -deficient homogenates with respect to succinate or NADH
(reduced nicotinamide adenine dinucleotide) concentration.
to prevent decline.

NADH seemed

This indicated that the metabolic lesion was in

the Kreb's cycle and the electron transport chain was unaffected (110).
Oxidation of certain substrates by liver homogenates from vitamin
E-deficient rats declined after a short time when compared to the rate
exhibited by livers from vitamin E-sufficient animals, but no such
decline was exhibited by the mitochondria from the deficient animals.
If the microsomes were added to the mitochondria or supernatant fluid,
there was an increased rate of decline, but boiled microsomes under the
same conditions produced only a slight decline.

The microsomes were

therefore felt to be the site of decline in oxidation (111).

Dietary

selenite largely prevented a fall in mitochondrial NADH-cytochrome c
reductase and pyruvate oxidation rates and in the P:O ratio in the
rat (112).
The agent in microsomes which caused respiratory decline by its
effect on the mitochondria was reported to be a heavy metal which reacted
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with sensitive sulfhydryl sites or similar points of attack.

The block

in the system was not in oxidative phosphorylation or in the mitochondrial
electron transport system but at certain dehydrogenase systems which
connect the tricarboxylic acid cycle to the cytochrome chain.

With a-keto-

glutarate as the substrate lipoyl dehydrogenase was found to be an enzyme
involved.

This enzyme is sensitive to trace metals and arsenite even

in the presence of reducing substrates (113).
In the absence of dietary vitamin E and selenite swelling of
axons in sensory relay nuclei or spinal cord and medulla of rats
developed.

Succinic dehydrogenase was the only enzyme measured that

was low in the swollen axons of the vitamin E-deficient animals.

Other

enzymes tested were NAD-(nicotinamide adenine dinucleotide) or NADP(nicotinamide adenine dinucleotide phosphate) diaphorase, NAD- and
NADP-dependent isocitric dehydrogenase, glutamic dehydrogenase, and
glucose-6-phosphate dehydrogenase (114).
Isocitric acid dehydrogenase in the skeletal muscle of the vitamin
E-deficient rabbit was decreased.

The serum isocitric acid dehydro-

genase decreased in moderate dystrophy but increased when dystrophy was
more pronounced.

The serum citrate levels decreased with an increase

in isocitric acid dehydrogenase (115).
Glutamic-pyruvic transaminase increased and glutamic-oxaloacetic
transaminase decreased in rabbit liver in the early stages of dystrophy.
Glutamic-pyruvic transaminase also increased in the muscle and serum of
the rabbit at this time.

As the disease progressed, this enzyme decreased

in muscle but was still elevated in the serum.

This suggested leakage
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through deteriorated cell membranes of muscle.

But glutamic-oxalo-

acetic transaminase decreased in muscle and did not increase in serum
in advanced dystrophy (116).
The level of different keto acids in the tissues from rats and
chicks was higher in vitamin E deficiency than in controls.

The glutamic-

oxaloacetic transaminase from chick serum and rat liver was higher in
vitamin E deficiency than in control animals (117).
Of thirteen antioxidants which prevented liver necrosis most also
prevented respiratory decline.

Vitamin E was inactive in vitro and

methylene blue was inactive in vivo, but methylene blue is in the leuco
state in vivo and is oxidized in vitro (118).

There was a lack of cor-

relation between the TBA (thiobarbituric acid) reaction and the decline
of succinate and a-ketoglutarate oxidation in the vitamin E-deficient
homogenate (119).
The TBA test for peroxidation is a measure of the amount of
rnalonaldehyde formed (120).

Cysteine and glutathione catalyzed lipid

peroxidation, causing malonaldehyde formation.

Tissue aldehydes and

sugars heated with hydrochloric acid also developed the color with
TBA incubation.

Linolenic acid would produce a positive test, but

arachidonic acid gave negative results (121).

In vitro tocopherol in-

creased synthesis of ascorbic acid, which catalyzes peroxidation of fatty
acids and inhibits its own synthesis.

Vitamin E also inhibited and

ascorbic acid increased malonaldehyde production.

Both prevent herna-

tin-catalyzed peroxidation of unsaturated fatty acids (122).

Due
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to the colors given by heme-containing systems in the TBA test it is
necessary to apply the test to erythrocyte membrane components in the
absence of heme in order to obtain reliable data on the oxidation of
these components (123).
Detection of peroxidation by TBA in liver homogenates from rats
fed vitamin E-deficient diets was increased by the presence of NAD-linked
substrates, but not by succinate.
respiratory inhibitors.

The peroxidation was prevented by

Evidence suggested that damage to cell fractions

might result in endogenous peroxide formation rather than the reverse
(124).

Phenergan and Versene prevented respiratory decline and liver

necrosis in vitamin E deficiency.

These must block a chain of reactions

in which trauma leads to a release of toxic breakdown products causing
further damage (125).
The microsomes from vitamin E-deficient rabbits were susceptible
to lipid peroxidation (126).

When homogenates from liver and muscle of

vitamin E-deficient animals were combined with homogenates from vitamin
E-sufficient animals, inhibition of peroxidation occurred only in the
liver.

The boiled homogenate from the liver of the vitamin E-sufficient

animal had no protective effect (127).
The effects of various dietary levels of selenium, vitamin E,
and DPPD on liver necrosis and lipid peroxidation were investigated.
Selenium prevented necrosis, but not peroxidation.

Vitamin E prevented,

at the levels administered, peroxidation, but not necrosis.

The effect

of vitamin E and selenium may therefore be on some other biochemical
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or biophysical system concerned with the maintenance of cell integrity
(128).

Selenium and cystine in some way alter the composition of tis-

sues (129).

In vitamin E deficiency in chicks a high capillary perme-

ability, associated with edema, was suggested as the cause of exudative
diathesis (40, 130).

Membrane permeability.

In skeletal muscle of vitamin E-deficient

rabbits aminoisobutyric acid rose faster and fell earlier than in controls.

This was not caused by changes in water content or intracellular

space.

It was suggested that vitamin E deficiency causes an increased

loss of amino acids from muscle cells due to increased membrane permeability and that the increased uptake is a compensatory mechanism (131).
Vitamin E deficiency caused an increase in erythrocyte permeability in
the rat (13 2 ) .
A comparison of vitamin A-deficient rats fed high or low levels
of vitamin E demonstrated an increased storage of vitamin A with the
higher level of vitamin E.

Vitamin A-deficient animals

1

when compared

to their vitamin A-sufficient controls, showed increased levels of
vitamin E in liver and decreased serum albumin but increased globulin
The in vitro incorporation of 14c-amino acids into diaphragm

levels.

protein was higher in vitamin A-deficient low vitamin E rats than in the
controls

1

but the incorporation of 14c-amino acids into protein from

diaphragm of the vitamin A-deficient rats with the higher vitamin E
level was lower than in the pair fed control.

These changes were
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explained as being from an effect of vitamin E and vitamin A on membrane
properties.

There was an increased permeability of cell membranes in

vitamin A deficiency.

This changed the amino acid pool inside the cell.

Vitamin E reversed the effect of vitamin A on the cell membrane.

This

would lower the loss of amino acids from the cellular pool (133).

The

action of the fat soluble vitamins on sulfomucopolysaccharides associated
with the cell membrane might cause these changes in permeability (134).
The increased permeability of various cells in vitamin E-deficient
animals may be due to release of lysosomal enzymes following peroxidation (40).

Aryl sulfatase, a lysosomal enzyme, was absent in control

animals but present in high concentration in vitamin E-deficiency (93).
Hamster skeletal muscle possessed proteolytic and autolytic activity
similar to that of rat skeletal muscle, and the enzyme activity of muscles
from both species was increased when made dystrophic by vitamin E
deficiency (135).

Increased proteolytic activity in the muscle of the

vitamin E-deficient rabbit has also been reported (136).
In an attempt to determine whether peroxidizability and increased
lysosomal enzymes occurred before or with dystrophy or

with the regres-

sion of dystrophy, the methionine added to a vitamin E-deficient chick
diet was removed.

Dystrophy developed within 48 hours.

After resupple-

mentation with methionine the lysosomes stayed high until almost complete recovery.

Peroxidizability also remained high on the vitamin E-

deficient diet with methionine repletion and returned to normal only
at the end.

The addition of vitamin E resulted in a slower return to
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normal than added methionine for both lysosomal activity and dystrophy.
Since there was no induction of lysosomal enzyme activity before the
symptoms of dystrophy developed, the increased lysosomal activity could
not have been the cause of muscular dystrophy in the chick (137).
The effect of the antioxidant DPPD in the prevention of muscular
dystrophy was not due to conservation of tocopherol in the tissues of
the rabbit.
diet.

DPPD caused remission of muscular dystrophy on a fat free

This was in accord with the view that muscular dystrophy is

associated with antioxygenic potency and also agreed with the activity
of a-tocopherylhydroquinone and a-tocopherylquinone.

DPPD, however,

did not prevent hypercholesterolemia and muscular degeneration in guinea
pigs fed a diet low in vitamin E (138).

Factor 3 did not influence

muscular dystrophy in rabbits, but vitamin E did (139).

Poultry nutritiono

In chicks exudative diathesis, encephalomal-

acia, and muscular dystrophy have been related to vitamin E-deficiency.
Exudative diathesis was most sensitive to selenium supplementation.
Each could be produced uncomplicated by the others, on the basis of
diet, and none of these was an uncomplicated vitamin E deficiency.

In

exudative diathesis the plasma protein was low and the albumin fraction
was particularly depleted.

Muscular dystrophy could be produced by

diets low in selenium and sulfur amino acids.

Encephalomalacia was not

prevented by selenium, but was prevented by most antioxidants (140).
Dystrophy in chicks due to deficiencies of vitamin E and sulfur
was associated with an elevation in the myocardial catecholamines (141).
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No muscular dystrophy occurred when chicks fed diets deficient in vitamin E and sulfur amino acids were also deficient in arginine (142).

As

the level of arginine in the diet was increased, the level of methionine
necessary for the prevention of muscular dystrophy was also increased.
The increased growth resulting from the amino acid supplementation might
be responsible for the increased methionine requirement.

Cystine and

methionine seemed to have a metabolic importance more specific than that
of supplying sulfur.

Vitamin E appeared to be interrelated with sulfur

amino acid metabolism (143).

Antioxidants and sodium sulfate added to

a low sulfur diet helped reduce muscular dystrophy in the chick (144).
Vitamin E was necessary for the development of chick embryos
(145).

In turkeys unsaturated oil in the diet accentuated a deficiency

of vitamin E.

Eggs from turkeys fed diets high in unsaturated oils

failed to hatch unless DPPD or vitamin E was added.

DPPD did not

increase tocopherol deposition in the egg yolk, but tocopherol did.
Pollack-liver oil caused a reduction in the tocopherol content of the
yolk (146).

High levels of vitamin E produced maximum hatchability.

Natural vitamin E was destroyed by fish liver oil in the diet, but this
oil did not increase the metabolic requirement for vitamin E (147).
Exudative diathesis and encephalomalacia rarely occurred on low
fat diets and could be altered by dietary changes not related to the
vitamin E status (130).
0.3 p.p.m. (148).

Selenium as selenite prevented diathesis at

In chicks with exudative diathesis fed diets defi-

cient only in vitamin E and selenium it was not possible to correlate
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the extent of in vitro lipid peroxidation with the severity of the
symptoms.

Selenium did not modify the amount or type of polyunsaturated

fatty acids.

Those antioxidants which went into the tissues were effec-

tive in preventing peroxidation (149).

The major portion of the require-

ment of the chick for vitamin E could be satisfied by a biologically
active antioxidant such as DPPD or ethoxyquin.

The antioxidant either

protected vitamin E carried over from the egg or replaced the vitamin
in its functions.

Less ethoxyquin was required to prevent encephalo-

malacia than to prevent muscular degeneration.

Vitamin E may function

as a prooxidant (150).
The activity of antioxidants was in vivo and was not only protection of the diet against autoxidation.

These compounds might sub-

stitute for vitamin E, but might also protect the vitamin that is
there (105).

When negative results occurred with an antioxidant, it

was felt that the wrong antioxidant had been used or that the level
was too low.

The antioxidant might also be toxic.

The hydroxyanalog

of methionine remedied deficiencies of the sulfur amino acids.

The

vitamin E deficiency symptoms could be brought about by low sulfur,
low antioxidant diets which produce dystrophy, low selenium, low antioxidant, high linolenic acid diets which produce exudative diathesis,
and high linoleic acid, low antioxidant diets which produce encephalomalacia (151).
Linoleic acid added to chick diets low in vitamin E resulted in
encephalomalacia.

This was uncomplicated by selenium deficiency or
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possible oxidation of fatty acids.
encephalomalacia.

Cod-liver oil in chick diets caused

Linoleic acid mLght destroy vitamin E in the diet

and gut during fatty acid oxidation or increase the destruction of
vitamin E in the tissues because of high levels of fatty acids and subsequent autoxidation, but antioxidants added to the diet would have
prevented this.

The linoleic acid mtght also disrupt some cell struc-

ture or metabolic process because of autoxidation of linoleic or
arachidonic acid in the tissues.

This is the supposed cause of the

influence of linoleic acid on the development of encephalomalcia (152).
When hog liver fractions were fed to chicks receiving a vitamin E-deficient diet, the most unsaturated fraction produced the most symptoms
of encephalomalacia and killed some of the animals before they could
develop exudative diathesis.

Otherwise, the less unsaturated the fatty

acid fraction, the less sick the animals became from exudative diathesis
(153).

Encephalomalacia in the chick could be accelerated by feeding

oxidized fats and fatty acid oxidation products (154).

Injections of

linoleate hydroperoxide also accelerated the development of encephalomalacia.

Vitamin E-deficient diets with accompanying high fat and

protein were more severely damaging (155).
Respiratory ~hain-electron transport.

Vitamin E has been sug-

gested as having a function as a cofactor in the terminal respiratory
chain just before cytochrome c (156).

Tocopherol could reverse

digitonin inhibition but no other substance commonly used could.
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Digitonin is used to solubilize mitochondrial enzymes and is usually
added to concentrated preparations which have to be diluted before
assay.

The inhibition could be reversed by dilution.

Digitonin also

inhibited succinate-cytochrome c reductase, but other factors could
reverse this inhibition.

However, NAD-cytochrome c reductase inhibi-

tion responded only to tocopherol (157).

In the NADH-cytochrome c

reductase system tocopherol was not oxidized or reduced.
might involve free radicals.

The reaction

The tocopherol bound to the enzyme might

function in electron transport, but it might be part of the lipid
sheath that maintains proper orientation for electron transport (158).
It may function indirectly as a binding or cementing substance for other
components of the cytochrome c reductase system (159).

The NADH-

cytochrome c reductase of particulate preparations was inactivated by
isooctane extraction but reactivated by a-tocopherol2

Several other

antioxidants did not replace the activity that vitamin E restored
(160).
Others have said that tocopherol is not a cofactor in the
cytochrome c reductase system.

They reasoned that the inbibitory

products came from aged enzyme preparations and tocopherol removed
these products (161).

DL-a-tocopherol and D-a-tocopherol seemed to

behave the same in restoring the activity of isooctane- extracted heart
muscle, suggesting that isooctane inhibited rather than extracted a
component of the enzyme system (162).
a physical inhibitor when some enzymes

The solvent might act as
were extracted with organic
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soJ~ents.

Tocopherol and other s6lvents were non-spe6ific"in rever§-

in~ inhibition (163~ .164)~
Slater has suggested that the structure of the mitochondrion is
altered in vitamin E deficiency to promote hydrolysis of X ---v I.

This

compound arises as follows:
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He later altered this scheme

slightly and applied it specifically to vitamin E metabolism (Figure 4)
(166).

The horse heart muscle preparation generally used contains both

a-tocopherol and ubiquinone, which are localized mainly in the mitochondria (167).

Oxyge~ consurrption.

Oxygen consumption in the skeletal muscle

of young rats born to mothers fed vitamin E-deficient diets was increased even in the absence of microscopic alteration in the muscle.
There was no effect in the liver (:68).

Muscle from vitamin E-deficient

rats and rabbits showed increased oxygen consumption (169).

The oxygen

consumption of hamsters fed vitamin E-deficient diets returned to normal
after the administration of vitamin E, but the muscles still did not
work well (170).

Dystrophic muscles from vitamin E-deficient animals
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Figure 4. Possible mechanism for respiratory control by oxidative
phosphorylation (158).
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had higher oxygen consumption 1 lower creatine content, and higher
chloride content.

Oral administration of a-tocopherol lowered oxygen

consumption toward normal within 27 hours (171).
Erythrocytes from vitamin E-deficient rats underwent in vivo
hernolysis in high oxygen pressures.

Conditions which increased the

rate of oxygen consumption increased sensitivity to oxygen pressure.
The red blood cells from the vitamin E-deficient animals took up
oxygen at twice·the rate as the controls (172).

Thyroxine protected

weanling vitamin E-deficient rats against hemolysis, but older animals
were not protected except in vitro (173).

When the effects of toco-

pherols, methylene blue, and glutathione on the manifestations of
oxygen poisoning in the vitamin E-deficient rat were measured, the
methylene blue protected against nervous system damage and tocopherol
against hemolysis, but neither protected against lung damage.
thione had some effect on the lung damage.

Gluta-

Sulfhydryl enzymes were

those that were damaged (174).
Oxygen at one atmosphere pressure inhibited brain respiration in
normal animals.

The respiration of minced brain decreased in oxygen

more than in air, particularly in the presence of glucose, sodium lactate1 or sodium pyruvate.

In the presence of sodium succinate the

tissue was not so sensitive to oxygen.

Lactic dehydrogenase and the

diaphorase of brain were not affected.

D-amino acid oxidase and xan-

thine oxidase were also poisoned.

These data suggested that pyruvate

oxidase, a thiol enzyme, was affected (175).

Thyroxine 1 dinitrophenol,
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tetrahydronapthylamine, adrenaline, pituitary extract, insulin, and
eserine enhanced oxygen poisoning.

The damage was from excessive and

rapid oxidation in nerve cells and was attributed to caron dioxide (176).
Vitamin E also helped guinea pigs to withstand high altitudes.
Thyroidectomy increased and injections of thyroxine or dinitrophenol decreased resistance to anoxia.

Thiourea and thiouracil increased sur-

vival time of rats in acute anoxia.

These are not only basal metabolism

depressants but are also water soluble antioxidants.

Presumably, the

higher the fat in the diet, the greater oxygen requirement the animal
should have, since the respiratory quotient would be lower.

The shorter

survival time under conditions of anoxia of rats fed high fat diets,
when compared to controls fed less fat, is apparently a reflection of
this increased oxygen requirement.

Higher than physiological doses of

tocopherol increased susceptibility to anoxia (177).

The stress of

vitamin E deficiency increased the iodine requirement (178), but there
was no evidence that the thyroid changed (179).

Xanthine oxidase and coenzyme

~

levels.

Vitamin E depressed

liver xanthine oxidase levels in rats fed low protein diets.

Methio-

nine countered the effect, but cystine had little value.

The coenzyme

A level in livers from necrotic rats was also depressed.

Dietary methio-

nine seemed to be diverted by vitamin E into other channels than the
synthesis of xanthine oxidase.

Low levels of coenzyme A in liver

necrosis might be due to a defect in the"utilizati6n of cystine for
formation of coenzyme A (180).

The rate of incorporation of 35 s-cystine

into liver coenzyme A was also depressed.

The diet used also caused
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decreased oxidative activity of the Kreb's cycle and decreased lipogenesis.

The incorporation of cystine into liver protein proceeded at

a high rate (181).

The suggestion was made that vitamin E might regu-

late sulfur amino acid metabolism (182).

Dietary selenium as selenite

increased incorporation of 35s-cystine into coenzyme A and liver protein in the rat (112).
In contrast, other workers believed that the coenzyme A level
was related to growth.

If the animal was growing, there was no dif-

ference in the coenzyme A level (183).
Determination of Vitamin E
Analysis for vitamin Eis complicated because most of the analytical methods measure total reducing materials present and are not
specific for tocopherol.

Such substances are chromenols, reduced ubi-

quinones, and other antioxidants.

Not all tocopherols are equally

active biologically (184).

Evaluation of Vitamin E Status
The vitamin E status in the rat cannot be simply defined.

Levels

of vitamin E in serum and fat do not change enough to be meaningful.
Other tissues must be assayed.

Heart muscle analysis has been suggested.

The level of the vitamin in the adrenal glands is high even in vitamin
E deficiency.

This is another factor indicating that the function of

the vitamin is not simply that of an antioxidant, because tissues most
subject to peroxidation do not have the highest levels of the vitamin
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(185).

Dietary selenite hsd no effect in changing tocopherol content

of rat liver (112).

!ransport and Storage of yitarnin .§_
Most of the ingested vitamin E goes to the liver 1 but transfer
to other tissues is rapid"

In man most of the vitamin is in adipose

tissue and only a little is in the liver.
with age, but there is

6

Generally, it increases

decrease in old age.

In rats removed from

their vitamin E-deficie:-i.t and -sufficient mothers on the 21st day of
gestation the tocophero:L levels were almost the same.

The vitamin E-

sufficient mothers had lower levels of the vitamin in sera, but liver
and muscle stores were higher (186).
There is a high concentration of vitamin E in adrenals, nerves,
heart, and uterus (1 7).

In chicken liver on the basis of nitrogen

content 20-23 per cent of the vitamin was in the nuclei, 44-45 per
cent in the mitochondria, and 33-35 per cent in the supernatant (188).
DPPD was found mainly in the soluble fraction of liver cells 1 mainly
in the microsomes.

Its distribution pattern was similar to that for

total lipids and not for vitamin E (189)"
There is a lipid present in yeast with certain properties similar to vitamin E (190).

This lipid is probably ubichromenol (191).

II.

SULFUR METABOLISM

Sulfur metabolism has been studied in animals both in vivo and
in vitro.

Many of the suggested mechanisms have been based on feeding
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experiments, with accompanying measurements of varying metabolites in
urine and feces or in blood or other body tissues.

Similar measurements

have been carried out after injection of radioactive isotopes.

Another

approach to the problem has been measurement or identification of products produced by incubation of tissue preparations and attempts to relate the results to in vivo work.

Absorption
Several studies have been carried out on the absorption of sulfur compounds.

L-, DL-, and ~-cystine were fed to fasted white

rats by stomach tube.

The rates of absorption were calculated by deter-

mination of the cystine in the gastrointestinal tract after 1, 2, and
3 hours.

For L- the rate was 49.9; D-, 45.6; and DL-, 53.6 mg. per 100

g. per hr.
hr.

But the rate for ~-cystine was 41.3 mg. per 100 g. per

Cysteine hydrochloride was slowly absorbed, 25.7 mg. per 100 g.,

per hr., but the sodium salt was abosrbed faster, 41.4 mg. per 100 g.
per hr.

The rates of absorption for D-, L-, and DL-methionine as the

sodium salts were 35.6, 35.7, and 38.2 mg. per 100 g. per hr. respectively (192).

There was evidence of cystine malabsorption in the small

intestine in cystinuria (193).
In Vivo Studies
Balance experiments.

Sulfur balance studies have been conducted

in rats to determine the requirements for dietary sulfur compounds.

In
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starvation the sulfur loss was approximately 36 mg. per kg. per day.
The deficit dropped with the length of time the diet was fed.

The de-

crease was in fecal sulfur, but there was more sulfur per gram of feces
than when the animal was eating.

The neutral sulfur in urine increased,

but free and conjugated sulfur decreased.

When the animal was fed a

sulfur-free diet, the loss was about 26 mg. per kg. per day.
weight loss in spite of good eating.

There was

Free sulfate disappeared entirely

in both urine and feces, and only neutral sulfur appeared in feces (194).
On similar diets to which methionine was added at the level of 0.053 to
0.15 parts per 100 parts sulfur or homocysteine at 0.094 parts per 100
parts sulfur, only the rats receiving the most sulfur had free sulfate
in the urine.

The conjugated urinary sulfate was constant and inde-

pendent of the diet.

The neutral sulfur was high.

At least half of

the sulfur excreted was in the feces and this was independent of ingestion.

The requirement for methionine in the adult rat was deter-

mined to be 30 mg. per kg. per day (195).
In other sulfur balance experiments in rats cystine and cysteine
were employed as sulfur sources.

Cystine was less beneficial than

cysteine, although the fecal excretion of cysteine was higher.

Con-

clusions were that cysteine could replace 87 per cent of the methionine
and cystine, 66 per cent (196).
In rats fed an otherwise sulfur-free diet sodium sulfate was
completely absorbed.

Sulfate would cover all a rat's needs for sulfur

compounds except that necessary for protein metabolism (197).
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When cats were fed a 3 per cent nitrogen, artificial amino acid
diet, removal of the sulfur amino acids had no effect on the rate of
nitrogen loss.

The cat apparently made methionine and cystine from

inorganic sulfate and has no exogenous requirement for the sulfur amino
acids (198).
If there was no other sulfate in the diet, sodium sulfate could
increase the growth and feed efficiency of chickens.

The chick could

satisfy part of its total sulfur requirement with inorganic sulfate.
Large amounts of methionine were incapable of satisfying the total sulfur requirement when fed to chicks on low sulfate-low cystine diets
(199).

Feeding and injection studies.

When 35s-methionine was fed to

.
rats, 35 S-cystine
was produced, but when 35 S-sulfate was fed to rats,
no cystine was produced.

This indicated that the animal could not pro-

duce cystine from sulfate.
hydrogen sulfide (200).

Cysteine did not exchange sulfur with

Methionine also produced taurine in the dog

35 S~Methionine could be incorporated into the tissue protein

(201).

of the dog even after hepatectomy.

Methionine could be converted to

cystine in such tissues as the kidney, pancreas, and intestinal mucosa
(202).
Most of the extra sulfur in urine after the administration of
DL-methionine and L-cystine, either oral or injected, was excreted as
sulfate.

Disulfide compounds were found in the urine of the rabbit
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after the administration of rrethionine.

When the a-amino group of

methionine was blocked, the sulfur excreted in the urine was in the
organic sulfur fraction.

The mechanism suggested is that the primary

reaction in the catabolism of methionine is demethylation (203).
In cystinuria in man homocystine, like cystine, could be completely
oxidized.

Homocysteine was excreted as cystine and homocystine.

much was oxidized to sulfate.

Not

Homocysteine is apparently the first major

intermediate in the conversion of methionine to cysteine (204).

In the

conversion of methionine to cysteine in vivo the sulfur of cysteine,
but not the carbon chain, came from methionine (205).
When the cystine excretion of normal humans was measured, there
was a positive correlation between cystine and neutral sulfur and between urinary cystine and creatinine, but there was no correlation between total nitrogen or body weight and cystine excretion.

Man excretes

a fairly constant amount of cystine regardless of diet (206).

When L-cys-

tine, L-cysteine hydrochloride, L-methionine, L-cystine disulfoxide, Lcysteinesulfinic acid, L-cysteic acid, and DL-methionine were administered,
cysteinesulfinic acid was poorly oxidized to sulfate, cysteic acid oxidation was negligible, and cysteine was not metabolized in the disulfide
form.

Since the oxidation of cysteine was greater than that of cystine,

which in turn exceeded cystine disulfoxide, cysteinesulfinic acid, and
cysteic acid, cysteinesulfinic acid was thought not to be an intermediate
in the oxidation of cysteine to inorganic sulfate in man.
must have occurred early in the process (207).

Deaminination
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Hypotaurine was isolated from extracts of urine from rats fed
.
( 2 08) .
a diet of 6 per cent cystine

35 s D
. .
.
After a dministration
of
- L-

ctstine, taurine, hypotaurine, thiotaurine, thiazolidine carboxylic
acid, and cysteinesulfonate were isolated from a kidney extract and
from urine (209).
The inner sulfur atom of thiosulfate was eliminated rapidly in
rats as sulfate, while the outer was transformed into sulfate much
more slowly.

Low sulfate and thiosulfate in the urine did not

necessarily mean low thiosulfate in the animal, because the thiosulfate pool might be large.

When 35 S-DL-cystine and thiosulfate, or

the cystine alone, were injected and the urine collected, cystine without thiosulfate produced almost no thiosulfate in the urine, but with
thiosulfate 33 per cent of the sulfur of cysteine was excreted in the
form of thiosulfate in 24 hours.

This was interpreted as meaning that

the large dose of thiosulfate inhibited the oxidation of endogenous
thiosulfate (210).
Rhodanese catalyzed exchange of 35 s between sulfite and thiosulfate.

When 35 s-cystine was injected into rats along with thiosulfate,

more 35s appeared in the urine as thiosulfate and less as sulfate.

This

indicated that thiosulfate is an important metabolic precursor for sulfate.

Sulfinates also participated in rhodanese-catalyzed transulfura-

tion reactions (211).
When cystine was fed to a rabbit, the oxidation to sulfate began
within three hours after absorption from the intestine and reached a
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maximum at eight hours.
(212).

Most of the excess sulfate was not conjugated

There was an increased excretion of sulfate in urine from rabbits

fed ~-mercaptopyruvate (213).
In rats fed a pyridoxine-deficient diet there was no increase in
taurine excretion after a cysteine load or after a cysteine and vitamin
B 6 load.

In a normal animal there was an increase in taurine excretion

after both treatments (214).

When cysteinesulfinic acid was admin-

istered to pyridoxine-deficient rats, measurement of the urinary products indicated that the desulfination reaction still was operating
normally (215).

In man vitamin B6 depletion resulted in failure to

respond to load doses of cysteine by increased taurine excretion, but
when both cysteine and vitamin B6 were administered at the same time,
increased taurine excretion occurred.

The level of vitamin B6 did not

affect sulfate excretion or nitrogen balance (216).

Injection of

cysteinesulfinic acid into sheep caused an increase in the thiosulfate
excreted in the urine (217).
Hypotaurine administered to rats was metabolized to sulfate and
taurine in the urine (218).

When taurine was administered to man, the

increase in sulfur excretion in urine occurred in the neutral sulfur
fraction (219).
When 35 s-N-acetyl-D-glucosamine-6-0-sulfate and other esters
were injected and urine and feces collected, most of the radioactivity
appeared in the inorganic and ester sulfate fraction within 24 hours.
Since some of the sulfate ester is metabolized to sulfate, the excre-

45

tory ester sulfate c.ould represent direct metabolism of the ester or
reincorporation of the sulfate formed (220).
Vitamin A has some influence on sulfur metabolism in the rat.
Excess vitamin A did not inhibit the oxidation to sulfate of 35 S-methionine or of

35

s-cystine, since the same proportion of total

35

s excreted

in the urine of both control and hypervitaminotic rats occurred as 35 so 4 .
When single or repeated vitamin A injections were given to rats treated
3 Sso 4 =
.
1y wit
. h 3 SS-met h ionine,
. .
.
.
previous
a 1arger amount o f inorganic
was excreted than in the controls.

After injection of Na 2 35 S04, vitamin

A-treated rats showed a more rapid decrease in the specific activity of
urinary inorganic sulfate than control rats (221).
Low protein diets caused reduced urinary excretion of injected
35 S-taurine.

The finding that the urinary excretion of taurine is depen-

dent upon dosage indicated a renal threshold for taurine or a limited
pool size for taurine or its metabolic products (222).
Tissue and excretory taurine increased in rats during fasting.
Tissue cystine and methionine also increased, but there was no correlation between urinary excretion of cystine and taurine.

No cysteic acid

could be detected in the tissues or urine of fasted rats.

Taurine in

zein-fed rats remained essentially constant when compared to the levels
in fasted ratso

This indicated that the normal course of oxidative pro-

cesses of the sulfur-containing amino acids might be impaired in fasting and that the conversion of cysteine to taurine became predominant (223).
Data on urinary sulfate excretion indicated that dogs oxidized
L- and DL-cystine, L- and DL-cysteine, and glu ta thione to the same degree
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(224).

After oral administration of cholic acid to fasted bile fistula

dogs for several days, the oral administration of methionine, homocysteine, cysteine, cystine, or cysteic acid with the cholic acid resulted
in an increased production of taurocholic acid in the bile while no extra
taurocholic acid was produced from homocystine.

Injection of methionine

sulfoxide, homocysteine, cysteine, cystine disulfoxide, cysteic acid,
cysteine-sulfinic acid, cystamine dihydrochloride, and thioglycolic acid
after cholic acid feeding caused no increase in taurocholic acid formation with the thioglycolic acid or cystamine dihydrochloride, but some
increase with the others.

These results indicated that dogs could not

make taurine from thioglycolic acid, cystamine dihydrochloride, or homocystine, but could from the other compounds tested.

Most of the excess

sulfur excreted in the urine after injection of homocysteine, cystine
disulfoxide, cysteine, cystine, cysteinesulfinic acid, cystamine dihydrochloride, and thioglycolic acid was as sulfate (225-229).

The urinary

sulfur excretion patterns indicated that the sulfur of homocystine and
homocysteine was oxidized to approximately the same extent as the sulfur
of cystine or methionine (225).

With methionine sulfoxide much of the

extra urinary sulfur appeared as organic sulfur, indicating that the
oxidation of this compound to sulfate was more difficult than the oxidation of methionine to sulfate (226).

Very little of the sulfur of

cysteic acid was oxidized to sulfate (229).
Bile loss aggravated a deficiency of organic sulfur in the rat.
35 s-taurocholate feeding led to 3 5s excretion in the urine of rats.

In

rats fed a chow diet and treated with 35s-taurocholate, 17 per cent of
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the sulfur administered was found in the bile and 45 per cent in the urine.
The animals fed a low organic sulfur diet had an equivalent amount of
sulfur in the bile, but less in the urine, and the specific activity
of the bile sulfur was higher (230).
The feeding of a-protein instead of casein led to hypercholesterolemia.

This was partially prevented by methionine supplementation.

There was little correlation between liver cholesterol and serum cholesterol in rats, and no atherosclerosis (231).

Diets high in cholestrol

and low in sulfur amino acids produced atherosclerosis in Cebus monkeys (232).
Since transport systems of sulfate, phosphate, amino acids, and
glucose are functionally interrelated, the same anatomical site is probably common for all (233).

Sulfate and thiosulfate mutually and strongly

inhibited each other's transport through the renal tubules by a competitive mechanism and share the same absorption mechanism (234).
With toxic levels of selenite there was abnormal bone and cartilage development in chick embryos.
tabolism.

This suggested disturbed sulfate me-

There was a significant increase in the µmoles of

35

S-sulfate

incorporated per mole of glucuronic acid and in the taurine content in
the animals fed excess selenium, but the umole of 35 s-sulfate incorporated
per mole of taurine was the same in both sets of animals (235).
When gypsum was used as fertili~er on pastures, it appeared that
excess sulfur in the herbage might be involved in the etiology of muscular dystrophy.

There was a high incidence of muscular dystrophy with

high inorganic sulfate in basal rations.

Excess sulfur must interfere
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with the metabolism of selenium.

Adding sulfate to a dystrophogenic

diet containing selenium reduced the prophylactic efficacy of selenium
(236).
The effects of sulfate on the toxicity of selenate, selenite, and
seleniferous wheat were measured, as well as the effect of sulfite and
thiosulfate on selenium toxicity.

Addition of sulfate to the rations

did not relieve the toxicity of the wheat.

Only when the toxic selenium

compound was selenate did administration of sulfate help (237).

Sulfate

seemed to affect urinary selenium excretion (238).
The quokka, a marsupial with digestion similar to ruminants, eats
plants deficient in copper and cobalt, high in sulfate, and moderate in
molybdenum.

When half the animals fed such plants were given sulfate

after all had been pretreated with molybdenum in addition to the normal
feed, there was a decrease in whole blood molybdenum and increased molbdenum excretion in urine (239).

In general, with a constant molybdenum

intake, blood levels of molybdenum decreased with increasing sulfate.
Supplementation of the diet with methionine or sodium sulfide was not
so effective as giving sulfate.

Tissue retention of sulfur was depressed

by dietary molybdenum, but the total sulfur of bones in molybdenum
toxicity was increased.
diets.

This toxicity was more critical on low protein

High dietary molybdenum induced copper deficiency, and copper

toxicity was cured by molybdenumo
molybdenum to phosphorus (240).
lytic effect on phosphate esters.

There was a similarity of behavior of
Molybdenum may exert an in vivo hydroMolybdenum led to an increase in

urinary and fecal phosphate in the rat (241).

49
Copper deficiency during molybdate toxicity is reported to be
caused by an accumulation of sulfide produced by sulfide oxidase.
cystine aggravated the symptoms.

Excess

An increase in dietary copper or inclu-

sion of dietary sulfate ameliorated the symptoms (242).
Sulfate may affect selenate transfer across membranes as postulated for molybdenum.

There should be a common mechanism of allevia-

tion by sulfate of selenate and molybdate toxicities (243).
Cystathionine has been identified by paper chromatography as a
constitutent of the liver following feeding of both L-methionine and
L-serine to a fasting rat.

L-methionine alone was ineffective in cysta-

thionine production (244).

When cysteine was injected into the rat,

there was increased alanine in the liver.
tion also increased.

The taurine-glycine concentra-

This warranted the assumption that taurine and

alanine were formed in the cysteine-injected animal (245).

After injec-

tion of 35 s-cysteine into a rat, sulfate incorporation was found in the
liver before hypotaurine and this before taurine (246).
was also identified as an intermediate (247).

Hypotaurine

Injection of cysteine-

sulfinic acid led to the production of alanine and hypotaurine in rat
liver (248).

Cysteic acid and hypotaurine have been identified in rat

brain (249).
Exclusive of synthesis in the digestive tract and exchange between
the sulfur of cysteinesulfinic acid and sulfite, the sulfur of sulfite,
but not sulfate, was utilized by the rabbit to make cystine, cysteinesulfinic acid, and taurine.

Cysteinesulfinic acid was apparently the

precursor for cystine and taurine.

After administration of 35 so =

3 '

so
35

s-cysteinesulfinic acid was identified in extracts of organs from

bacterially sterilized or eviscerated animals (250).
Taurine is a major component of the amino acid fraction of most
organs.

The level is highest in the heart and varies in the liver (251).

In the rat the liver taurine level is 0.1 to 0.6 mg. per g. of liver for
the male and 0.7 to 1.1 mg. per g. for the female.

Since these values

do not correspond to the cysteic acid decarboxylase activity, there may
be other pathways for the formation of taurine in the rat (252).
When 35 s-taurine was administered to chick embryos, day-old chicks,
and rats, there was some incorporation into tissues.

This does not fit

with the classical description of taurine as a biologically inactive endproduct of cystine metabolism (222).
When the laying hen was injected with 35 s-sulfate, 35 s was present
in the albumen of the egg as dialyzable and non-dialyzable sulfate and
organic sulfur.

35 s was present in the yolk primarily as dialyzable sul-

fate and non-dialyzable organic sulfur.

Eighty per cent of the non-dialyz-

able sulfate in the egg yolk was attached to the yolk membrane.

Some

radiation was present in cystine, but none was found in methionine.
hen could incorporate sulfate into cysteine (253).

The

The chick embryo,

however, incorporated sulfate into taurine rather than into cystine.
Over 65 per cent of the sulfate administered to a 24 hour embryo was recovered as taurine in the day-old chick, presumably in the absence of
microorganisms.

Taurine was free in tissues and could not be considered

primarily as a part of taurocholic acid (2'54)•.
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In studies of the incorporation of uniformly labeled

14

c-glucose

into the hexosamine part of cartilage mucopolysaccharides, the isotope
appeared in the galactosamine part of the light mucoprotein fraction and
then in the insoluble residue.

The label went into chondroitin sulfate

first before it entered keratosulfate, suggesting that different compounds
were precursors.

Cortisone inhibited sulfate fixation.

It may be that

cortisone had no direct effect on sulfate fixation or chain synthesis but
influenced the availability of simple precursors for the formation of the
polysaccharide chain.

This may be related to capillary permeability or

diffusion of nutrients to the cell responsible for synthesis (255).
The presence of an active sulfate-synthesizing enzyme system in
cultivated connective tissue was determined.

Granulomata activity of

the PAPS- (3'phosphoadenosine-5'-phosphosulfate) synthesizing system was
at a maximum 96 hours after implantation of a cotton pellet and 48 hours
after implantation of a cotton pellet with carrageenin.

High doses of

cortisone inhibited the PAPS-synthesizing system in both the ordinary
granulomata and in those induced by carrageenin.

Sulfate was transferred

from PAPS to the mucopolysaccharide at the mucopolysaccharide level.

The

rate of mucopolysaccharide synthesis was sex dependent, but there was no
difference in the sulfate-activating enzyme system in either male or
female rats.

The rate of mucopolysaccharide synthesis for the female

was half that of the male (256).
After intrapertioneal injections of 3 5s in the rat, of the tissues
measured the bone marrow had the most 35 s regardless of whether the source
was heptylaldehyde bisulfite, cinnamaldehyde bisulfite, or sodium sul-
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fate (257).

After administration of 35s-sodium sulfate, most of the

radiation was found in chondroitin sulfate and some in taurine, with
the maximum radiation occurring in chondroitin sulfate at 24 hours and
in taurine at 8 hours (258).

Rats could convert 0.02 per cent of a dose

of 35s-sodium sulfate to cystine (259).

Most of the 35 s-sulfate was con-

centrated in the suckling rat in the knee joint (260).

Sulfate increased

in the bone up to 8 hours and in the bone marrow up to 24 hours after
intraperitoneal administration of 3 5 s-sodium sulfate.

The administration

of 1 mg. of 35 s-sodium sulfate led to the excretion of 95 per cent of
the dose in the urine after 5 days (261).

In the rat fetus the level

of 35 s in the kidneys, liver, and lungs corresponded to the level in the
pregnant rat.

The level was lower in the fetal gastrointestinal tract.

The level of radiation in the fetal humerus was three times that in the
maternal sternum, fifteen times greater per gram of embryonic biceps
femoris than in the pregnant rat, and more per gram in embryonic brain
and skin.

The older embryos incorporated more radiation than the younger

in the same length of time.

There was definite transfer of sulfate to

the fetus (262).
In the detoxication of phenols the first sulfur to be used was
probably the sulfate in the cell fluids.

When this was removed, it

was replaced by oxidation products of metabolism.

When the fluids

were depleted by administration of phenols, sulfate accumulated slowly
over a series of days as it arose from the metabolism or diet until
excretion became normal.

The dog could utilize oral or injected sodium

sulfate to make phenyl or indoxyl sulfate from phenol or indole (263).
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Sulfate did not help in growth resumption after growth was stopped
by the administration of p-bromophenol, but cystine did restore growth.
This resumption correlated with increased excretion of ethereal sulfates (264).

In Vitro Studies
A summary of the possible pathways for the oxidation of the
sulfur of cysteine to sulfate in animals is given in Figure 5.

Cystathionine

~

substrate.

In vitro metabolism of the sulfur

compounds has been studied extensively.
cystathionine has been isolated.

An enzyme for the cleavage of

It did not produce ammonia from DL-

serine or homoserine, but did produce hydrogen sulfide from cystine.
It seemed to be cysteine desulfurase (265)0

A dark red enzyme from

liver catalyzed the deamination of homoserine and cleavage of cystathionine.

Cysteine, a product, inhibited (266).

It is unlikely that

homoserine was derived metabolically from cystathionine in the liver
of the rat.

No radioactivity could be found in homoserine following

cleavage of 14c-cystathionine by a crystalline enzyme of rat liver, but
14c-cystathionine could be produced from 14c-homoserine and cysteine
(267).

The cystathionine synthetase-serine dehydrase activity was re-

pressed when rats were fed low methionine-cystine diets for a week.
Cysteine added to the incubation mixture did not inhibit the enzyme (268).
Cystathionase is probably identical with soluble cysteine
desulfurase and perhaps the same as serine dehydrase and threonine
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dehydrase (269).

Cysteine desulfhydrase activity was lower in rats

treated with thyroxine and greater in thyroidectomized rats (270-272).
The enzyme activity was not changed after adrenalectomy but increased
after the administration of hydrocortisone.

When rats were injected

with cysteine, L-methionine, or DL-homoserine and the hydrogen sulfide
formation measured after sacrifice of the animal, cysteine administration had no effect on hydrogen sulfide formation, but homoserine and
methionine increased it.

The enzyme was apparently adaptive (271).

Cystathionase in rat liver acted upon cystine and hypotaurine
to make thiotaurine.

A similar reaction took place with cysteine.

This

reaction was apparently due to the oxidation of cysteine to cystine,
because no pyruvic acid was produced when cysteine was used in an anaerobic system, but pyruvic acid was produced under similar circumstances
from cystine.

The proposed mechanism is that two cysteines combine to

form cystine, which then forms thiocysteine and pyruvate.

The thiocys-

teine reacts with a compound such as cysteinesulfinic acid to form
cysteine and thiocysteinesulfinic acid (273).

Sulfite can react with

cystine and cystamine to form S-sulfocysteine and S-sulfocysteamine
(274).

It has been reported with another incubation system, that cysta-

thionase acts on cysteine, not cystine (275).
In rat liver there is an enzyme which converts sulfocysteine to
thiosulfate, ammonia, and pyruvate.
aminoethylthiosulfuric acid.

No thiosulfate was produced from

Sulfite was formed from both thiosulfate

esters under anaerobic conditions, and the production was augmented by
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heat denaturation.
(276).

Sulfite could be detected under anaerobic conditions

Rhodanese could be reactivated by sulfhydryl compounds such as

cysteamine, mercaptoethanol, or thioglycolate (277).
D-amine oxidase from hog kidney acted upon cystamine to form
cystaldimine and other products.

With labeled compounds thiotaurine

was produced and thiocysteamine was suggested as the intermediate.

The

pathway may involve cystamine to cystaldimine to thiocysteamine to
thiotaurine and hypotaurine (278).
to cysteamine and sulfur (279).

Thiocysteamine could be decomposed

There is also an enzyme that catalyzes

the oxidation of cysteamine to hypotaurine in the presence of sulfide
or sulfur.
(280, 281).

The sulfur may function as a hydrogen carrier to oxygen
Certain reducible dyes may be used as cofactors for the

enzymic oxidation of cysteamine to hypotaurine (280).

Alanine thio-

sulfonic acid reacts with a-ketoglutaric acid in the presence of rat
liver mitochondria to form thiosulfate.

This reaction took place with-

out the consumption of oxygen and suggested elimination of sulfite and
sulfur rather than reaction to give thiosulfate (282).
of hypotaurine required oxygen (283).

The oxidation

The oxidation of hypotaurine

has also been studied by Sumizu (284).
Cysteine
ways.

~

substrate.

Cysteine can be split in vitro in many

One of these is a direct desulfurization producing pyruvate,

ammonia, and hydrogen sulfide (285).

In rat liver the enzyme for the

direct desulfhydration is in the supernatant fraction (286).

Cystine

is thought by s~me to bet~ true substrate for desulfhydration.

~-
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Mercaptopyruvate was used as an artificial substrate because it and
hypotaurine should react to form thiotaurine, and this should be an
indication of cystine transamination.

If hypotaurine could derive its

sulfur from both ~-mercaptopyruvate and thiocysteine, then hypotaurine
should be derivable from cysteine by two pathways.

Since no a-keto-

glutarate was required, the conversion must involve cystathionase (285).
A transaminative mechanism of degradation of cysteine has also
been reported.

The transaminase is in the particulate fraction (286).

Cysteine and a-ketoglutarate were converted to glutamate and what should
be ~-mercaptopyruvate in heart and liver preparations.

The ~-mercapto-

pyruvate should decompose to sulfur or sulfide and pyruvic acid (287).
~-Mercaptopyruvate desulfurase has been found in the particulate fraction (288).
Both ammonia and hydrogen sulfide were formed during incubation
of L-cysteine with liver extracts, but hydrogen sulfide production was
always greater than the production of ammonia.

a-Ketoglutarate had no

effect, but pyridoxal phosphate caused a rise.

Glutamic acid and ala-

nine were produced without cysteine in the presence of a-ketoglutarate.
The suggestion was made that both transamination and desulfuration reactions operate (289).

Dog and rat liver extracts could remove hydro-

gen sulfide from cysteine anaerobically without the production of
ammonia.

There was greater activity with L-cysteine than with D-

cysteine (290).

No hydrogen sulfide could be isolated from a living

animal; so the place of this in vitro enzyme was questioned (291).
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Two soluble rat liver enzymes, one heat stable and the other
heat labile, were required to catalyze the aerobic oxidation of sulfide
to thiosulfate (292).
liver.

No polythionate was formed from sulfide in

Free heme was an active catalyst for the oxidation of sulfide.

Sulfide oxidase activity could be demonstrated only under rather
unphysiological conditions, and thiosulfate probably arose from ~-mercaptopyruvate and sulfite.

The sulfide oxidase activity of liver

homogenates was probably due to the presence of hemoglobin in these
preparations (293).

If sulfite was replaced by sulfinate, thiosul-

finates could be formed (294).
Serine sulfhydrase in chick liver will degrade cysteine to
serine and hydrogen sulfide (295).

The enzyme could be reduced by

low protein or protein-free diets and increased by high protein diets
rich in gelatin.

L-cysteine, L-histidine, cortisone, histamine, fast-

ing, and thiouracil increased activity.

Methionine, glutamic acid,

arginine and thyroprotein decreased activity (296).
Mn+ 2 was found to inhibit cystine oxidase, as measured by
oxygen uptake in rat liver, but there was no inhibition in kidney and
brain (297).

In addition to the formation of cystine from the reaction

of cysteine with oxygen in tissues, sulfate, carbon dioxide, and sulfite were also formed.

Cysteic acid did not produce sulfate.

There

was a suggestion of a feed-back mechanism with excess taurine or cysteic
acid leading to sulfate production (298).

In rat liver 3 per cent of

the cysteine given formed sulfate and 65-89 per cent formed cystine
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(299).

Liver and kidney had about the same activity toward cysteine,

but blood, testis, spleen, heart, and lung of the rat were inactive.
Cysteine, rather than cystine, was the preferred substrate.

Liver and

kidney could also oxidize methionine (300).
In an aerobic reaction cysteine could be converted to cysteinesulfinic acid by enzymes from rat liver.

Hydroxylamine was used to

inhibit the conversion of cysteinesulfinic acid to other compounds.
Fe+2 and NADPH were cofactors.

ATP, hypoxanthine, cytochrome c, hydro-

. 1 ating
.
.
gen peroxi. d e, Mg +2 , Mn +2 , and Cu +2 ha d no effect on stimu
cysteine-

sulfinic acid formation (301).

The role of cysteinesulfinic acid in

the production of sulfate from cysteine has been questioned as a pathway for rat liver mitochondria (302).

However, a supernatant prepara-

tion from liver did produce cysteinesulfinic acid from cysteine.

Less

cysteinesulfinic acid was produced when 35 s-cystine was incubated with
the enzyme preparation.

Both 3 5s-glutathione and ~5S-cysteine produced

cysteinesulfinic acid (303)"
lated

Cysteinesulfinic acid has also been iso-

from an incubation medium after incubation of a rat liver homo-

genate with cysteine (304).
When radioactive cystine was administered to the rat, 25 per
cent of the radiation was found in hypotaurine and only 1 per cent in
cysteinesulfinic acid.

This indicated to the experimenters that there

was a rapid turnover for cysteinesulfinic acid and that hypotaurine
was derived metabolically from cysteinesulfinic acid and not from
cysteic acid (305),
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C<.:E~teinesulfinic and cysteic acids~ substrates.

The two main

in vivo and in vitro reactions in rats for cysteinsulfinic acid are
desulfinating transamination to produce sulfite, which oxidizes to sulfate, and decarboxylation to form hypotaurine, which oxidizes to taurine.
Both reactions should require pyridoxal phosphate.

In the vitamin B6 -

deficient rat taurine and hypotaurine disappeared from the urine, and
the rat excreted cystathionine.

Enzymes prepared from pyridoxine-

deficient rat liver did not decarboxylate cysteinesulfinic acid, while
transamination with a-ketoglutarate was not inhibited.
transamination was inhibited, however.

Pyruvic acid

Decarboxylation of cysteinesul-

finic acid was two to three times greater in male than in female rat
liver.

Removal of the ovaries in the female enhanced decarboxylation,

while estradiol given to ovarectomized females made decarboxylation
return to normal levels (306).
In fresh rat liver mitochondria there may be an NAD-linked
enzyme which anaerobically converts cysteinesulfinic acid to ~-sulfinyl
pyruvate and ammonia (307, 308).
lated as sulfite.

In heart mitochondria sulfur accumu-

In the opinion of the authors the accumulation of

pyruvate and sulfate as the end-products of the aerobic metabolism of
cysteine in animal tissues lent further support to the view that
cysteinesulfinic acid is on the major pathway of the metabolism of
cysteine (307).

Alanine is also reportedly formed in rat liver from

cysteinesulfinic acid.

The pyruvate normally considered to arise

from cysteinesulfinic acid by transarnination should lead to the produc-
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tion of alanine, but evidence indicates that alanine is not produced
from pyruvate.

This suggests that there is direct cleavage of the

cysteinesulfinic acid to alanine and sulfite in rat liver (309, 310).
The liver made more decarboxylated product than it did alanine and
sulfite (311).

Cysteinesulfinic acid led to increased carbon dioxide

production by livers from the rabbit, rat, and dog, but not from the
horse and cat.

Taurine in man might be formed by a different path-

way (312).
Decarboxylation of cysteic acid by livers from male rats was
greater than by livers from female rats.
the male and female rat brain.

The activity was equal in

Ovarectomy made the decarboxylase

activity in the female approach that in the male, but there was more
taurine in the female than in the male.

This suggested that taurine

formation in liver is independent of the decarboxylation of the sulfur
amino acids (313).

The enzyme for the decarboxylation of cysteine-

sulfinic acid and cysteic acid was thought by some to be the same in
liver but not in brain (314-316), but not by others (317).

Both the

enzyme in liver and that in brain required free thiol groups and
pyridoxal phosphate.

The decarboxylase is a supernatant enzyme for

liver, but the brain enzyme may be in the particulate fraction (315).
There was no cysteinesulfinic or cysteic acid decarboxylase in mammalian heart tissue, but there was a high concentration of taurine
in this tissue (316).

The cysteic acid transaminase in heart muscle

is probably a different enzyme from cysteine transaminase (287).
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Cysteine was an inhibitor for the decarboxylation of cysteinesulfinic and cysteic acids in the rabbit.

The brain enzyme also was

active with glutamic acid, but the liver enzyme was active only with
the sulfur acids (318).
decarboxylase.

Isoniazide inhibited cysteinesulfinic acid

Hydroxylamine inhibition was reversible (319).

Brain

tissue from cat and man can decarboxylate cysteinesulfinic acid.

The

decarboxylation of cysteic acid and cysteinesulfinic acid was mutually
inhibitory (316).
Cysteic acid may be on the pathway of taurine synthesis in the
cat (320).

Dog heart slices could make taurine from cystine.

thionic acid (2-hydroxyethanesulfonic acid) was also produced.

IseThis

acid may dominate the cell membrane potential by accumulating cations
(321).

Taurine, by serving as a precursor of isethionic acid, may

have a role in regulating the irritability of cardiac tissue (322).
Sulfite as substrate.

Ground embryonic calf liver could produce

hypotaurine and cysteinesulfinic acid from sulfite, but not from taurine
or cysteine.
of serine.

Cysteinesulfinic acid formation decreased in the presence
Cysteinesulfinic acid could not be reduced to cystine under

the conditions employed, but the reaction does take place in vivo (323).
A hemoprotein enzyme which oxidizes sulfite to sulfate has been
partially purified from liver preparations.

The enzyme is localized

largely in the microsomal fraction of liver, heart, and kidney (324).
Rat liver mitochondria could couple the oxidation of sulfite with the
synthesis of ATP (325).
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Sulfate and PAPS as substrates.

There was a high level of sul-

fate incorporation into the colonic mucosa of sheep (326).
degraded by an enzyme from sheep brain.
and co+ 2 and Mn+ 2 activated it.
ADP and sulfate (327).

ADP inhibited the degradation,

The products of the degradation were

In the small intestine of the rat PAPS will

form PAP-so 3 = with NADPH in the presence of ATP.

For the production

of S-sulfoglutathione, PAPS+ GS- (glutathione)---+
phosphoadenosine-5'-phosphate).

GSS03

=

+ PAP (3'-

Or PAPS+ a reducing agent will make

PAP+ 803 = and 803- + GSSG ~GS-+ GSS03 .
considered to be the most likely.
intestinal mucosa.

PAPS was

The second reaction was

This reaction took place in the

There was no activity in rat liver (328).

S-sulfo-

glutathione might be formed in vivo by the addition of a sulfate to a
cysteinyl residue or of sulfite to cystinyl.

Sulfate could be reduced

in the rat intestine (329).
.
.
h.ig her 35 s activity
· ·
·
A rat liver
homogenate h a d 20 - so times
in
the protein after incubation with H2 35 s than it did after incubation

. h
wit

H2 358 04.

After intracardial injection of either compound the

protein radioactivity was 8 times higher with H2 35s.

The conclusion

was that the rat was not able to reduce sulfate to sulfide (330).
The sulfokinase present in a tissue is related to the mucopolysaccharide component of the tissue.

Chondroitin sulfate B could not

replace chondroitin sulfate A or Casa sulfate acceptor, and chondroitin
sulfate B was not in cartilage (331).

The transfer of sulfate to

chondroitin sulfate from PAPS was inhibited by sulfate for chondroitin
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sulfate A, but not for chondroitin sulfate B (332).

When a particle-

free high-speed supernatant fraction from the rat liver was incubated
with ATP, sulfate, and Mg+2, the rate of formation of PAPS decreased
with increasing length of incubation time and eventually the amount of
PAPS actually decreased.

This could be because sulfate was being trans-

ferred to various acceptors such as phenols and steroids.

Versene

suppressed the formation of PAPS and inhibited the 3'-nucleotidase of
rat liver which degrades PAPS to APS (adenosine phosphosulfate).

In

the absence of ATP and Mg+2 PAPS produced sulfate (333).
PAPS served as a sulfate donor to heparin in the mouse mast cell
tumor (334).

PAPS with a cell-free extract of human adrenals led to

the sulfation of testosterone and some other steroids, but not to sulfation of cortisone, hydrocortisone, or aldosterone (335).

Chondroitin

did not act as a sulfate acceptor nor influence the incorporation of
glucose into chondroitin sulfate (336).

A priming mechanism for the

synthesis of isomeric chondroitin sulfate is proposed (337).
The inner egg-shell membrane, which contains a sulfated mucopolysaccharide, is secreted by the isthmus of the hen oviduct.

Many

mucopolysaccharides accept sulfate from PAPS, but the rate varies for
each acceptor (338).

PAPS was a precursor for the sulfated polysaccha-

rides in the isthmus of the hen oviduct (339).
Phenol conjugation almost disappeared in the absence of sulfate
in one strain of rats (340).

A 10 per cent fresh liver homogenate from

rat bound sulfate to phenol (341).

PAP was a product rather than a par-
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ticipant in the enzymic conjugation of phenols with sulfate.

The

PAPS available for sulfation might be regulated by a nucleotidase
capable of degrading PAPS (342).
Non-Enzymic Reactions
Many non-enzymic reactions led to the production of the various
metabolites proposed for cysteine.
thiol-disulfide exchange (343).

Excess thiols reduce disulfides by

Cysteine, alanine thiosulfonic acid,

S-sulfocysteine, cysteic acid, ammonia, and thiosulfate were formed
from the oxidative degradation of cystine in alkaline medium with copper
(344).

Pyridoxal and cu+ 2 at pH 8.5 converted cystine to pyruvate,

ammonia, carbon dioxide, sulfur, thiosulfonate, cysteinesulfinic acid,
and alanine thiosulfonate.

Sulfinates make more thiosulfonates.

Thiopyruvic acid transulfurates sulfinates.
given in Figure 6.

The apparent pathway is

The transulfuration of cysteinesulfuric acid leads

to alanine thiosulfonate.

Cysteinesulfinic acid and thiosulfate come

from the hydrolytic cleavage of thiocystine (345).
The detachment of the thiol of cysteine by pyridoxal and metals
such as aluminum or vanadium is reversible.

Cysteic acid is synthesized

in the presence of sulfite (346).
Cysteamine will react with oxygen and sulfur or sulfide to make
cystamine.

Methylene blue is also active in place of oxygen.

The sul-

fide can also react with oxygen to produce sulfur and polysulfide (280).
The dismutation of cystine disulfoxide produces the sulfinic
acid, which is the most stable oxidation product.

Cystine and water
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will make cysteine and cysteinesulfinicacido
cystine and cysteinesulfinic acid (347).

The sulfenic acid produces

Cysteic acid can also be pro-

duced from ~-substituted amino acids, pyruvate, and copper ions.
Cysteinesulfinic acid and sulfite make cysteic acid.

Cysteic acid can

come from serine, phosphoserine, or cysteinesulfinic acid in the presence of cu+ 2

and pyruvate or pyridoxal.

With pyridoxal other metals

can be used to replace copper, but copper is specific for pyruvate (348).
Many of the inorganic sulfur compounds available are either not
so pure as the label would indicate or decompose rapidly in solution.
When metabolites are measured 1 t~ lack of purity can lead to false
conclusions (349).
The catalytic oxidation of glutathione and other sulfhydryl
compounds by various inorganic compounds has been studied.

Selenate

and selenite were equally active catalysts for glutathione oxidation.
Tellurite inhibited selenite oxidation but did oxidize glutathione.
Sulfite did not inhibit selenite catalysis or catalyze glutathione
oxidation.

Arsenite inhibited glutathione oxidation when added 30

minutes before selenite, but not when added simultaneously.
is a better catalyst for cysteine oxidation than copper.
good

Selenite

It is also a

catalyst for dihydrolipoic acid and coenzyme A oxidation (350).

Methods
Several methods have been used for the separation of various
sulfur metabolites by passage through ion exchange resins (351~358).
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When acid paper chromatography solutions were used with taurine and
related compounds, streaking occurred in the chromatograms.
pass through resins (351).

Urea will

In a phenol-ammonia solvent the ~f values

for taurine and glycine and for cysteinesulfinic acid and aspartic acid
were similar (359).

Iodine, potassium iodide in hydrochloric acid, and

potassium iodoplatinate sprays, as well as ninhydrin, have been used
to develop the chromatograms (360-362).

CHAPTER III

EXPERIMENTAL

Io

GENERAL PLAN

Since previous results in this laboratory had indicated that vitamin E was necessary in vivo not only for the optimal sulfation of mucopolysaccharides, but also for the oxidation of neutral sulfur to sulfate
(1), the ability of whole liver homogenates from vitamin E-sufficient and
-deficient rats to convert cysteine to sulfate was investigated.

Then

an attempt was made to determine the specific site of the decreased oxidation of cysteine or its intermediate oxidation products.

Low sulfate

diets were employed to force the animals to satisfy their inorganic sulfate needs by the oxidation of the sulfur amino acids.

Diets
The composition of the basic diets appears in Table 1.

These

diets were modifications of that of Pendergrass (363) originally modified from Caputto et al. (27).

Similar diets have also been used in

previous studies in this laboratory (364-367).,

The salt mixture

was a modification of that of Hubbell et al. (368) to give 0.0002 per
cent inorganic sulfate in the diet.

The composition of the modified

salt mixture appears in Table 2a
The basal diet was generally mixed in 4 to 6 kg. lots, the
quantity prepared being determined by the amount of diet expected to
69
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TABLE 1
COMPOSITION OF EXPERIMENTAL DIETS

sCLO
g./100 g.

+CLO
g. /100 g.

Browna
g./100 g.

15.00

15.00

18.00

0.35

0.35

Sucrose

30.35

30.35

32.00

Cornstarch

32.30

32.30

34.00

8.00

6.00

5.00

10.00

10.00

6.00

2.00

I.00

Comeonent
Case in, vitamin freeb
DL-Methionineb

Stripped lardc
"Alphacel," non-nutritive bulkb
Cod-liver oil
Salt mixture

3.ood

3.ood

3.ooe

Vitamin mixturef

1.00

1.00

LOO

aunpublished.
bNutritional Biochemicals Corp., Cleveland, Ohio.
cDistillation Products Industries, Inc., Rochester, New York.
d

See Table 2.

eHubbell, Mendel and Wakeman Salt Mixture, Nutritional Biochemicals Corp., Cleveland, Ohio.
fsynthetic vitamins added as supplement to each 100 g. of diet:
(in mg.) nicotinic acid, 20.0; pyridoxine•HCl, 0.5; thiamine•HCl, 0.5;
riboflavin, 0.5; calcium pantothenate, 1.0; folic acid, 0.5; biotin,
0.005; 2-methylnaphthoquinone, 0.025; vitamin B12, 0.005; choline
chloride, 100.0; inositol, 100.0; .e.-aminobenzoic acid, 7.5. The vitamins were triturated with sufficient sucrose to make 1.0 g. DL-atocopherol acetate was added to the sufficient diets at the level of
28 mg. per 100 g. diet~ Vitamin A acetate and vitamin D (Viosterol)
were added to the diets ic10 at the level of 400 and 200 I. U. per 100
g. of diet, respectively.
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TABLE 2
COMPOSITION OF SALT MIXTUREa

Composition

Grams per 100 Grams

CaC03

44.750

MgC03

3.060

NaCl

6.900

KCl

11. 200

KH 2 P04

21. 200

FeP04 • 2H20

2.050

KI

0,008

NaF

0.010

MnCl2·4H20

0.040

AlK(S04)2· 12H20

0.017b

Cu(C2H302)2·H20

0.072

Cornstarch

10.693

aHubbell et al. (368), as modified by Pendergrass (363).
b

Correct weight only if the anhydrous salt is used.
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be consumed completely in from 10 days to 2 weeks.

At the time of prepa-

ration the diet was mixed thoroughly by hand and then sieved through
household strainers several times to insure uniformity.

The appropriate

quantity of vitamin E (28 mg. per 100 g. diet) was added to half the
quantity of diet at this time.
was repeated on this portion.

This is the +E diet.

The sieving process

The feed was stored in clean, dark-colored

jars at refrigerator temperature until used.

As precautions against

autocatalytic rancidity, clean jars were used for each new diet preparation, and all remaining old diet was fed to the animals rather than
being mixed with the new preparation.
given ad libitum until sacrifice.

Feed and distilled water were

For the prevention of deterioration

of feed in the cages the animals were generally fed daily only slightly
more than the amount they were expected to consume.

The cage papers

were changed and any feed remaining in the feed cup was cleared of
debris three times a week.

If appreciable amounts of feed had been

thrown from the feed cups to the papers below, this was sifted and refedo

Distilled water was given fresh three times a week.

bottles were used as needed.

Clean water

Stoppers for the bottles were kept clean

by rinsing thoroughly in hot water each time the water was changed and
then transferring them to new bottles.
rare occasions.

Feed cups were changed only on

These precautions were necessitated by the fact that

feed residue from the stock diet often became deposited on the inside of
the stoppers and spouts and was incompletely washed out of the feed cups
also used by the stock colony.

Even though these appeared to be clean,

the contamination from t~ high vitamin E content of the whole wheat,
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whole milk stock diet seemed to prevent hemolysis on the vitamin E
deficient diet.

At no time did the diet smell rancid.

Animals
Selected littermate al~ino rats of the Wistar strain from the
University of Tennessee stock colony were used as tissue donors.

Both

male and female rats were used~ but each test group consist~d of only
one sex.

The young rats were placed on vitamin E-sufficien"': and -de-

ficient diets containing O.OOG2 per cent sulfate (Table 1).

Generally,

the animals were weaned at 21 days of age and fed the experimental
diets,

Exceptions will be mentioned.

At some time prior to sacrifice

blood was withdrawn from tai.~ cuts to establish vitamin E deficiency
by dialuric acid hemolysis.

Generally, except for one animal in the

sCLO (without cod-liver oil) study, the animals were considered to be

vitamin E deficient only when the hemolysis values from the animals fed
the diet unsupplemented with vitamin E were greater than 90 per cent.
The erythrocytes from the sE animals usually exhibited hemo1.ysis after
four weeks of feeding the experimental diet.
earlier,.

No animals were tested

Both the vitamin E-def icient animal and the -sufficient

littermate were then killed on the same day, and all samples treated
in paralleL
The term "prepprd" refers to animals whose mothers had been fed
the sE sCLO diet (Table 1) two weeks before the litters were weaned.
These uprepped" anima1s were littermates to those used by Button in her
Experiment 7 (364).
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The animals were generally weighed weekly and checked for gross
defects.

The only defect generally noted was the reddish discharge on

the whiskers noted by Button (364), which developed after about the
fourth week of feeding the vitamin E-deficient diet.
Animals were housed in galvanized metal cages according to diet.
When only a few animals were available at the start of an experiment,
all, regardless of sex, were housed in the same cage.
ever, separation was also made by sex.

Generally, how-

Except for the first few weeks

of the sCLO experiment, the animals fed the vitamin E-deficient diet
were always housed above the animals fed the other diet.
For ·all but the experiment measuring cysteinesulfinic acid formation by the quantity of ninhydrin-positive material formed, the animals
were decapitated after light ether anesthesia.

In this experiment the

animals were stunned by a blow to the head before decapitation.
In a supplementary study to measure the effect of increased
organic and inorganic sulfur in the diet upon the ability of liver
homogenates to oxidize the sulfur of cysteine to sulfate, livers were
obtained from four pairs of animals raised and used as sources of tissue by Brown.*

The animals had been fed the 18 per cent casein normal

sulfate diet included in Table 1.
In another supplementary study to measure the effect of increased
inorganic sulfate in the diet upon the ability of liver homogenates to
oxidize the sulfur of cysteine to sulfate, livers were obtained at the

*R. G. Brown, unpublished.
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termination of the experiment from animals fed the diet described as
the normal sulfate (0.02 per cent sulfate) diet used for a collagen
study in this laboratory (369).

This diet was essentially the +E+CLO

diet (Table 1) with an equal weight of the Hubbell, Mendel, and Wakeman
salt mixture* substituted for the low sulfate salt mixture normally used.

II.

METHODS

Preparation£!_ Enzyme Solutions
Several methods of preparing the enzyme were used.

All homogeni-

zations were performed in motor-driven glass homogenizers placed in ice
baths.

Unless otherwise specified, not more than 90 minutes elapsed

between killing and the start of the incubation.

The whole liver homogenates.

The whole liver homogenates were pre-

pared in 0.067 M. sodium phosphate, buffered at pH 7.4; the same buffer
containing 0.002 per cent Versene (disodium ethylenediaminetetraacetic
acid); the same buffer with 0.005 per cent Versent-Fe-3;** or 0.05 M.
potassium phosphate, buffered at pH 7.8 and containing 0.005 per cent
Versene-Fe-3.

Specific buffers used for each experiment are indicated

in Tables 4-9 in the results.
The liver fractions.

All solutions used were cold.
The liver homogenates were fractionated in-

to mitochondria (370) and supernatant fluid.

Ammonium sulfate was added

*Nutritional Biochemicals Corp., Cleveland, Ohio.
**Fisher Scientific Company, Fairlawn, New Jersey.
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to the supernatant fluid to 0-50 per cent and 50-70 per cent saturation.
The mitochondrial and ammonium sulfate fractions were then rehomogenized
with buffer and the ammonium sulfate fractions dialyzed against the buffer
at refrigerator temperature until no sulfate could be detected in the
surrounding media.

Since the phosphate in the buffer was insoluble when

tested with barium chloride, it was necessary to acidify the samples from
the surrounding media before testing for sulfate.
pension was frozen until used.

The mitochondrial sus-

Before assay the ammonium sulfate frac-

tions were recentrifuged to remove protein denatured in the process of
dialysis.

The whole liver homogenate was assayed the day after prepara-

tion, the mitochondria were thawed and assayed the day after that, the
0-50 per cent fraction on the next day, and the 50-70 per cent fraction
on the next.

Two pairs of experimental animals were processed at a time.

Specifically, a small portion of the liver was homogenized in
buffer (Table 7) and stored until use at refrigerator temperature.

The

remainder of the liver was then homogenized in a cold solution containing 0.35 M. sucrose, 0.035 M. potassium bicarbonate, 0.004 M. magnesium
chloride, and 0.025 M. potassium chloride.
solution were used per gram of liver.

Three milliliters of this

The homogenate was then centri-

fuged at 700 x g_. for 10 minutes at 0° in a Lourdes refrigerated centrifuge.

The supernatant fluid was decanted and the residue (the

nuclei) discarded.

The supernatant fluid was then centrifuged at

14,000 x .[• for 10 minutes.

The particulate fraction containing the

mitochondria was then homogenized in 5 ml. of buffer and frozen.

To the

supernatant fluid remaining after removal of the mitochondria 0.35 g. of
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(NH4) 2 S04 was added per mlo of liquid.
equilibrate for about an hour.
10 minutes at 14,000 x ~·

The system was allowed to

The fraction was then centrifuged for

The residue (the 0-50 per cent fraction)

was homogenized with 10 ml. of buffer and dialyzed against this buffer
until free of sulfate.
To the supernatant fluid remaining after the above centrifugation
0.15 g. of (NH4)2S04 was added per ml. of liquido

The system was

allowed to equilibrate for about an hour and was then centrifuged for
10 minutes at 14,000 x ~-

The residue (the 50-70 per cent fraction)

was then homogenized with 25 ml. of buffer and the resulting solution
dialyzed until free of sulfate.
~

denucleated homogenates.

The fresh liver was homogenized

with 0.067 M. sodium phosphate buffer, pH 7.4, containing 0.005 per
cent Versene-Fe-3 and centrifuged at 1,200 x _g_. for 10 minutes in a
Lourdes refrigerated centrifuge at 0° to remove the nuclei.
The supernatant preparations.

The fresh liver was homogenized

with buffer (Table 10 in the results) and centrifuged at 10,000 x

£·

for 15 minutes in a Lourdes refrigerated centrifuge at 0° to rem~e
the nuclei and mitochondria.

Similar preparations have been used by

Sorbo and Ewetz (301).
The acetone powder extracts.

A 2.5 per cent homogenate of ace-

tone powder in 0.05 M. potassium phosphate, buffered at pH 7.8 and containing 0.005 per cent Versene-Fe-3, was shaken for two hours in the
cold and centrifuged at 1,200 x _g_. at 0° to remove the non-extracted
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material.

This is essentially the beginning step in the fractionation

procedure used by MacLeod et al. (324).
The preliminary purification of the enzyme.

Rat liver acetone

powder was homogenized with ten volumes of 0.05 M. potassium phosphate,
buffered at pH 7.8 and containing 0.005 per cent Versene-Fe-3.

The

homogenate was heated for 5 minutes at 56°, cooled for 10 minutes in an
ice bath, and centrifuged at 3,200 x _g_. for 10 minutes at 0°.

One volume

of cold 95 per cent ethanol was added slowly to the supernatant fluid.
The mixture was stored in the cold for from one to two hours and the
precipitate removed by centrifugation as before.

The crude enzyme was

removed from the supernatant fluid by the addition of 1.5 volumes of additional cold ethanol and collected by centrifugation after one hour.

The

precipitate was extracted with a volume of buffer equivalent to the volume
of the supernatant fluid remaining after the first centrifugation.

The

undissolved material was removed by centrifugation and the supernatant
fluid chromatographed on a 2.5 x 25 cm. column of DEAE-cellulose,* which
had been prepared as detailed by MacLeod et al. (324).

The reddish-orange

fluid was allowed to pass almost entirely into the column and the effluent
was discarded.

Then 100 ml. portions of 0.05 M., 0.10 M., 0.15 M.,

0.20 M., and 0.25 M. potassium phosphate, each buffered at pH 7.8 and
containing 0.005 per cent Versene-Fe-3, were added after the less concentrated eluant had passed almost entirely into the column.

Fractions

of 20 ml. each were collected.

*Cellulose, diethylaminoethyl ether, Matheson Coleman and Bell,
Norwood, Ohio.

79
Enzyme Assays
Several methods were used to assay the enzymes involved in the
oxidation of cysteine.
Oxidation of cysteine to sulfate.
ployed by Patrick (371).
in the results.

The assay resembles that em-

Experimental details are given in Tables 4-9

After addition of the trichloroacetic acid the protein

precipitates were removed by filtration and washed.
then concentrated and acidified.
chloride.

The filtrates were

Sulfate was precipitated with barium

Sufficient carrier sulfuric acid was added to insure 12 mg.

of barium sulfate.

The precipitate

was collected on glass fiber filter

papers, placed on planchets, and counted.

This is essentially the method

of Katz and Golden (372) without previous combustion.

The specific

activity of the cysteine used was determined by the method of Katz and
Golden (372).

A Nuclear-Chicago windowless gas-flow counter was used

for all measurements of radioactivity.

The period of incubation was

chosen because it gave a maximal difference between autoxidation and
formation of sulfate due to enzyme activity, and the net sulfate formed
was proportional to enzyme concentration.*
Oxidation of sulfite to sulfate.

Oxidation of sulfite to sulfate

was measured by an adaptation of the ferricyanide assay method (324, 373).
All reagents used in the assay were prepared in 0.05 M. potassium phosphate buffer, pH 7.8, containing 0.005 per cent Versene-Fe-3.

*J. To Smith, unpublished results.

The
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incubation system consisted of Ool mlo of the acetone powder extract;
3 pmoles of K3Fe(CN) 6 , prepared in buffer; 10 pnmoles of Na2S03; and
sufficient buffer to make a final volume of 6 mlo

All tubes were pre-

pared with buffer and the potassium ferricyanideo

The sodium sulfite

was added and mixed.

The enzyme solution was added, mixed, and the

opitcal density of the reaction mixture determined immediately with a
Bausch and Lomb Spectronic 20 colorimeter at 420 muo

The sample was

allowed to stand for exactly ten minutes at room temperature, and the
optical density was measured a second time.

Controls without sulfite

were also employed to measure the reduction of the ferricyanide by the
enzyme preparationso

These values were subtracted from those obtained

for the enzymic reduction of ferricyanide.
The 2,6-dichlorophenolindophenol assay of MacLeod et al. (324)
was also tried on similar extracts.

This time a boiled enzyme solution

was used to measure the non-enzymic reduction of the dye.

Oxidation of cysteine to sulfite.

Sulfite production from cysteine

by denucleated homogenates was measured by the method of Grant (374) as
modified by Leinweber and Monty (375).

The basic incubation mixture

consisted of 1.0 ml. of denucleated 10 per cent liver homogenate in 0.067
M. sodium phosphate buffer, pH 7.4, containing 0.005 per cent Versene-Fe-3;
200 }!moles of 35 S-cysteine-HC1, neutralized and diluted in this same
buffer; 100 Jlnmoles of MgCl2; 10 pnmoles of ATP, prepared in buffer; and
sufficient buffer to make a total of 5 ml.
in air for 1.5 hours at 37°.

The mixture was incubated

1be enzymic activity was destroyed by

adding Oo5 ml. of a 1 per cent solution of KOH in 95 per cent ethanol
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and 1 .0 ml. of a saturated solution of HgCl2 o
centrifuged.

The samples were then

One milliliter samples of the resultant supernatant fluid

were then placed in test tubes and 4 ml. of a color reagent consisting
of 11 ml. of concentrated sulfuric acid? 234 ml. of distilled water,
4 ml. of a 1 per cent solution of basic fuchsin in ethanol, and 1 ml.
of 40 per cent formaldehydeo

This reagent had been decolorized with

Norit A as suggested by Leinweber and Monty (375), and the Norit A had
been removed by gravity filtration.

After the color had developed for

15 minutes, the optical density of the samples was determined in a KlettSummerson photometer with a green (520 mu) filter.
set to zero with a reagent blank.

The instrument was

The color reagent was prepared fresh

daily, and, because it was oecasionally defective, it was always tested
against a known sulfite solution to make certain that the color would
develop before the reagent was used with the samples resulting from the
incubation procedure.

The sulfite standards were prepared in the Versene-

Fe-3 buffer, since this seemed to increase the stability of the sulfite
in the presence of mercuric chloride, and, as a result, increase the
sensitivity of the method.

An amount of mercuric chloride equivalent

to that in the samples was added to each standard.
Oxidation of cysteine to cyste,inesulfinic acid.

The formation

of cysteinesulfinic acid from cysteine was assayed in two ways.

De-

nucleated homogenates from female rats were used without added inhibitor, and supernatant preparations from both male and female rats were
used with hydroxylamine added as an inhibitor.
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The basic incubation mixture and reaction conditions for the
formation of cysteinesulfinic acid from the denucleated homogenates were
identical to that used for the oxidation of cysteine to sulfite.

The

enzyme was denatured by placing the tubes in boiling water for 10 minutes.
The tubes were then cooled and centrifuged at 2000 rev./min. for 10
minutes in an International Model SBV, Size 1, centrifuge to remove the
precipitates.

Any cysteinesulfinic acid framed should be converted to

sulfite by incubation with a-ketoglutaric acid and glutamic-oxaloacetic
transaminase (375).

Therefore, a measured sample of the supernatant

fluid was incubated for 15 minutes with 0.1 ml. of a solution of glutamicoxaloacetic transaminase prepared by dialyzing a combination of 1 ml.
of the commercial enzyme preparation* and 2 mL of 0.05 M. potassium
phosphate, buffered at pH 6.8, against this same buffer for about 16
hours.

An additional factor in the incubation mixture was 0.2 ml. of a

solution of a-ketoglutaric acid, prepared by dissolving 275 mg. of the
acid in 4 ml. of 0.5 M. K2HP0 4 and 10 ml. of 0.2 M. K3 P04, adjusting the
pH to 8.0, and diluting to 25 ml. with water.

Enough 0.05 M. potassium

phosphate, buffered at pH 7.8 and containing 0.005 per cent Versene-Fe-3
was also added to the incubation mixture to make a total volume of 2 .5 ml.
The activity of the glutamic-oxaloacetic ttansarninase was then destroyed
by the addition of the same quantities of alcoholic potassium hydroxide
and mercuric chloride used for the destruction of the enzymic activity
in the oxidation of cysteine to sulfite, and the analysis for the sulfite

*Sigma Chemical Company, SL Louis, MissourL
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formed proceeded as before.

Corrrrnercial cysteinesulfinic acid** was used

as a standard to check reagents for the entire procedure.
For the supernatant preparations with an inhibitor the incubation procedure is described in Table 10.

The procedure is essentially

that of Sorbo and Ewetz (301) for the isolation of cysteinesulfinic acid.
The supernatant fluid resulting from the centrifugation of the tubes
after destroying the enzyrnic activity with hydrochloric acid and
trichloracetic acid was placed on a Dowex 50 x 8 column (1 x 5 cm.)
in the hydrogen formo

The precipitate was washed twice with 5 ml. of

a 0.01 N. HCl solution and the precipitate separated from the supernatant
solution each time by centrifugation.

The supernatant solutions were

added to the appropriate column after the previous addition had passed
into the column.

The effluents from the original solution and the two

washings were combined.

Then 50 ml. volumetric flasks were placed under

the columns, and sufficient 0.01 N. HCl was added to the columns to bring
the effluent volume to 50 ml.

Both portions of the effluent were

quantitatively transferred to separate 50 ml. beakers and placed in an
air-convection oven at 67° until they reached dryness, usually overnight.
Two milliliters of water were added to each beaker to dissolve the
material.

Aliquots of the resulting solutions were then analyzed for

ninhydrin-positive materials.

A maximum of Oe5 ml. of the solution to

be analyzed was pipetted into a test tube, and 0.5 ml. of the buffer
solution and 5 ml. of the phenol reagent were added to each tube and

**Calbiochem, Los Angeles, California.
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the contents mixed thoroughly with a Vortex Jr. mixer.
of the ninhydrin reagent was added.

Then 0.5 ml.

The tubes were again mixed and

placed in a boiling water bath for 5 minutes, removed, and placed
in cool tap water for a few minutes.

Three milliliters of 60 per

cent ethanol were added to the samples and the standards during
cooling if the salt concentration was such that the phenol-water mixture in any of the samples formed an emulsion.

This was usually the

case with all samples of the first effluent.

All samples were again

mixed thoroughly with the Vortex Jr. mixer.

The experiment was per-

formed so that the determination of the optical density of the samples
in the Klett-Summerson photometer could begin about ten minutes after
the samples were removed from the boiling water.

mp) was used.

A green filter (520

The instrument was set to zero with a reagent blank.

The usual standards used were 1.5 J1moles of cysteinesulfinic acid per
ml. and 3 )lmoles of taurine, which had been recrystallized from water,
per ml.

The buffer solution (pH 4.3) was prepared by dissolving 5 g.

of Versene and 240 mg. of KCN in 300 ml. of 2 N. sodium acetate and
700 ml. of 2 N. acetic acid.

The phenol reagent was prepared by dis-

solving 400 g. of melted phenol in 100 ml. of absolute ethanol.

Five

grams of permutit were added and the solution was stirred for ten
minutes.

The permutit was removed by gravity filtration.

For the

ninhydrin reagent 6 g. of ninhydrin were dissolved in 100 ml. of absolute ethanol.

Two grams of permutit were added, and the solution

was stirred with a magnetic stirrer for ten minutes.

The solution was

filtered by gravity filtration, and the clear yellow solution was stored
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in a brown bottle,,
e.t al. (376).

This procedure is essentially that given by Fisher

The reason that the effluents were separated was that

checks of known solutions indicated that taurine was eluted in the ficst
fraction and cysteinesulfinic acid in the last

fraction..

essential agreement with results obtained by Wainer (303).

This is in
Samples from

both fractions, prepared from the same solutions used for the ninhydrin
determination, were also analyzed for cysteinesulfinic acid as described
above.

Since it was not known what material would be present in the

liver that might produce ninhydrin-positive material from the incubation
mixture, identical incubation mixtures had been prepared with boiled
enzyme preparations being substituted for the undenatured preparations.
The values obtained for ninhydrin-positive material formed in these reaction mixtures were subtracted from the values obtained for the undenatured preparations.
In another attempt to isolate cysteinesulfinic acid duplicate
samples to those reported in Table 9 in the results were prepared.

The

enzymic activity was destroyed by the addition of 20 ml. of 95 per cent
ethanol.

The tubes were centrifuged at 2000 rev./min. for 10 minutes

in an International ~odel SBV, size 1, centrifuge.

The supernatant

fluid was decanted into a separatory funnel, and 75 ml. of chloroform
were added and mixed.

The layers were allowed to separate and the

chloroform layer was removed and discarded.
was used by Awapara (377).

This extraction procedure

The aqueous layer was tested for the pres-

ence of cysteinesulfinic acid by the method of
(375)~

[rrweber and Monty

The sE extracts and the +E extracts were combined and concen-

86

trated.

They were subjected to paper chromatography with l-butanol--

1-propanol-O.l N.

HCl (1:1:1, v/v) and water-saturated phenol +0.5

per cent ammonia.

A ninhydrin spray was used to aid in identification

of the samples.

This is essentially the procedure used by Wainer (303).

Oxygen uptake of preparations incubated with cysteine.

The

oxygen uptake of various enzyme preparations was measured in a Warburg
respirometer at 37° in an air atmosphere with cysteine as the substrate.
Measurement of ATP effect.

The conversion of cysteine to sul-

fate by whole liver homogenates was measured in the presence and absence
of ATP.
Nitrogen or Protein Content of Enzyme Solutions
Nitrogen content of enzyme solutions was measured by the microKjeldahl method (378) for whole liver homogenates, denucleated homogenates, mitochondrial homogenates, and supernatant preparations.
Protein content of the ammonium sulfate fractions and acetone powder
extracts was measured by the method of Lowry et al. (379) with casein
as the standard.

The protein content was converted to nitrogen con-

tent with the casein factor.
The micro-Kheldahl method.

A measured volume of the solution to

be analyzed was pipetted into a 30-ml. Kjeldahl digestion flask containing 1.25-1.35 g. of K2 S04 and 35-45 mg. of HgO.

Two milliliters of
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concentrated sulfuric acid were added and the flask contents digested
until the solution became clear.

About 5 ml. of water were added to

dissolve the material, and, after the flask had cooled, the contents
were quantitative!~ transferred to a steam distillation apparatus.
Eight milliliters of the sodium hydroxide-sodium thiosulfate solution
were then added and distillation begun.

Approximately 45 ml. were dis-

tilled into 5 ml. of a saturated boric acid solution containing 4 drops
of either the methyl red-bromcresol green or methyl red-methylene blue
indicator.
0.02 N. HCl.

The amount of nitrogen was determined by titration with
The milligrams of nitrogen were calculated by the follow-

ing formula:
(Ml. acid) • (N. acid) • (Meq. wt. nitrogen) =mg.nitrogen.
The sodium hydroxide-sodium thiosulfate solution was prepared
by dissolving 500 g. of NaOH and 50 g. of Na 2 S203•5H20 in sufficient
water to make one liter.

The saturated boric acid solution was pre-

pared by dissolving 40 g. of H3 Bo 3 in about 900 ml. of distilled water
with heating, cooling the solution, and diluting to a final volume of
one liter.

The methyl red-bromcresol green indicator was prepared

mixing 5 parts of 0.2 per cent bromcresol green with 1 part of 0.2
per cent methyl red, both in 95 per cent ethanol.

The methyl red-

methylene blue indicator was prepared by mixing 2 parts of 0.2 per
cent methyl red with 1 part of 0.2 per cent methylene blue, both in
95 per cent alcohol.

by
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The

;o~,;r_y method.

A measured quantity of the solution to be

assayed was dissolved in 0.5 N. NaOH,.and diluted to a known volume
with the base.

Five milliliters of reagent A were mixed with one milli-

liter samples of the protein solution.

After the samples had stood for

at least 10 minutes at room temperature, 0.5 ml. of reagent B was
added rapidly and mixed.

After at least 30 minutes the absorption was

measured in a Klett-Summerson photometer with a red (770 mp) filter.
A casein standard was measured in a similar way to obtain a standard
curve.

Reagent A was made by adding 1 ml. of 2.7 per cent sodium potas-

sium tartrate tetrahydrate and 1 ml. of 1 per cent CuS04·5H20 to 100
ml. of 2 per cent Na2C03.

For reagent B commercial Folin-Ciocalteu

reagent * was diluted with enough water so that it contained 1 N. acid.
Assay of Erythrocyte Sensitivity to Dialuric Acid
The susceptibility of erythrocytes to chemical hemolysis by the
procedure of Friedman et al. (52) was selected for the determination of
the vitamin E status of the animals.

About 30

fl.

of blood were with-

drawn with a hemoglobin pipette from a transverse cut in a tail vein
of the rat and added to 5 ml. of a saline-phosphate buffer solution in
a 15 ml. conical centrifuge tube.

The cells were suspended by tapping

the tube gently and then collected by centrifugation at 2000 rev./
min, for 10 minutes in an International Model SBV, size 1, centrifuge.
The supernatant fluid was withdrawn with suction, and the cells were
resuspended in approximately 3.5 ml. of saline-phosphate buffer.

One

*"Bancou Phenol Reagent, distributed by E. H. Sargent and Company.
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milliliter of this cell suspension was pipetted into each of three
test tubeso

One milliliter of dialuric acid solution was added to

each of tubes 1 and 2.
added to tube 3.

One milliliter of saline-phosphate buffer was

The tubes were then incubated in a water bath at 37°

for one hour and left standing at room temperature for another hour.
At the end of this period, 5 ml. of the saline-phosphate buffer were
added to tubes 1 and 3 and 5 mlo of water to tube 2Q
were mixed and then centrifuged as before.

The contents

The optical density of the

supernatant fluid was determined in a Klett-Summerson photometer with
a blue (420 mp) filter.
water blank.

The instrument was set to zero with a distilled

Per cent hemolysis is calculated with the following form-

ula:
Per cent hemolysis =

Klett Reading 1 - Klett Reading 3
Klett Reading 2 - Klett Reading 3

X

100.

The saline-phosphate buffer was prepared by combining equal parts
of 0.1 M. phosphate buffer, pH 7.4, and isotonic saline solution.

The

phosphate buffer was made by dissolving 14.2 g. of anhydrous dibasic
sodium phosphate in distilled water, adding 20 ml. of 1.0 N. hydrochloric acid, and diluting to one liter.

Isotonic saline was 0.89 per

cent sodium chloride in distilled water~

The dialuric acid solution

was prepared by dissolving 10 mg. of dialuric acid in 50 ml. of salinephosphate buffer immediately before use.

This test was performed on

all deficient animals before sacrifice and on a few of the sufficient
animals as controls.
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Statistics
Statistical analysis was done by the method of paired comparisons or by analysis of variance (380).

The validity of these methods

may be questioned because some of the data tested may appear to have
come from a skewed population; however, the samples involved (4 to
12 animals) are too few to establish that the underlying population
is skewed.

CHAPTER IV
RESULTS
The effects of the dietary treatments upon the animals and upon
the oxidation of cysteine to cysteinesulfinic acid, sulfite, and sulfate and of sulfite to sulfate are given below.

Io

EFFECT ON ANIMALS

The uprepped" vitamin E-def icient female.s used in the fractionation studies (Table 7) were the only animals that appeared to be abnormal.

These exhibited the arching of the back reported in the early

literature on vitamin E (381).

The weight gains of the +E rats from

weaning to 12 weeks on the diet were very highly significantly greater

(f < 0.005)

than their

sE

littermates by analysis of variance, and there

was a significant interaction

(f <... 0.05)

between the effect of "prepping'·'

and the effect of vitamin E supplementation when these animals were
compared to nnon-prepped" animals fed the same experimental diets from
weaning.
For the other females only after the experimental diets were fed
for over five months was there a significant difference in the weight
gains of the animals, with the deficient animals gaining significantly

(E_

< 0.05)

less weight than their littermate controls.

This is in

agreement with a previous report in the literature (381).
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Only in the male animals fed the experimental diets for nine
weeks from weaning or for more than three months if placed on the
diets after only a few days on the stock diet was there a significant

Cf<

0.05) difference in weight gain in vitamin E deficiency.

All

these animals were still gaining weight, but the sufficient animals
were gaining more.

Growth and feed efficiencies of young adult male

rats fed the sCLO diets are given in Table 3.

Additional information

on growth is given in the tables accompanying the metabolism studies.

II.

EFFECT ON SULFUR METABOLISM

The results presented in Table 4 show a decrease in the conversion of the sulfur of cysteine to sulfate by whole liver homogenates
from vitamin E-deficient young adult male rats compared to their
vitamin E-sufficient controls.

Table 5 reports the decreased conver-

sion of cysteine to sulfate by whole liver homogenates from vitamin Edeficient adult male rats compared to their vitamin E-sufficient controls.

These differences were statistically significant (~

< 0.05).

Table 6 shows the conversion of cysteine to sulfate by liver
homogenates from vitamin E-sufficient and -deficient adult female
rats.

There was no statistically significant difference in the ability

of the two sets of animals to convert cysteine to sulfate.
Table 7 shows the ability of various liver fractions from
"prepped't female rats to convert cysteine to sulfate.

All the fractions

investigated exhibited increased sulfate formation from cysteine when

93

TABLE 3
GROWTH AND FEED EFFICIENCY OF YOUNG ADULT MALE RATS FED
THE DIET WITHOUT COD-LIVER OIL

Weaning
Weight
(Grams)

Animal

Death
Weight
(Grams)

Weight
Gain
(Grams)

Feed
Eff icienci

Dais on Diet

sE

1

32

225

193

0.44a

34

2

36

213

177

0.38a

36

3

34

209

175

0.40

41

4

30

206

176

0.37

43

5

38

233

195

o. 36

48b

34

217

183

0.39

Mean

+E
1

34

197

163

0 .. 45

34

2

38

213

175

0.40a

36

3

36

211

175

0.39

41

4

34

228

194

0.38

43

5

40

283

243

0.38a

48

36

226

190

0.40

Mean

a

Shared cage.

bLess than 90 per cent hemolysis.
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TABLE 4
CONVERSION OF CYSTEINE TO SULFATE BY LIVER HOMOGENATES FROM VITAMIN ESUFFICIENT AND -DEFICIENT YOUNG ADULT MALE RATsa

Pair Number

Vitamin E
Deficient
Sufficient
pmoles .. sulfate formed per mg, nitrogen

1

0.20

0.39

2

0.71

1.13

3

0.64

1.41

4

0.35

0.66

Q • 48

± 0 . 12b 'C

0.90 t 0.23

aThe basic incubation mixture contained 0.2-0.6 ml. of a 20
per cent whole liver homogenate in 0.067 M. sodium phosphate, buffered
at pH 7.4; 125 pmoles of 35S-cysteine-HC1 in buffer; 100 pmoles of
MgCl2; 10 pmoles of ATP in buffer; 0.18 pmoles of NAD in buffer; and
sufficient buffer to make 5 ml. The samples were incubated in air at
37° for 2 hours. Enzymic activity was destroyed by the addition of 5
ml. of 10 per cent trichloroacetic acid, The sources of tissue were
male rats raised from weaning forbetween 5 and 7 weeks on the sCLO
diet given in Table 1. The sE animals weighed from 206 to 233 g. at
death while the +E animals weighed from 197 to 283 g.
bMean ± standard error of the mean.
(380)

cstatistically significant by the method of paired comparisons
0.05).

<K <.
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TABLE 5
CONVERSION OF CYSTEINE TO SULFATE BY LIVER HOMOGENATES FROM VITAMIN ESUFFICIENT AND -DEFICIENT ADULT MALE RATSa

Vitamin E
Pair Number

Deficient

Sufficient

ymoles S04= formed per mg. nitrogen
I

0.22

I. 27

2

0.49

0.82

3

0.47

0.85

4

1.34

I. 62

5

I.29

1.18

6

2.03

2.95

0.97 :t o.28b,c

I.45 ± 0.32

aThe basic incubation mixture contained 0.5 ml. of a 10 per cent
whole liver homogenate in 0.067 M. sodium phosphate buffered at pH 7.4;
125 pmoles of 35 s-cysteine-HC1 in buffer; 100 pmoles of MgCl2; 10
pmoles of ATP in buffer; and sufficient buffer to make 5 ml. The
samples were incubated in air at 37° for 1.5 hours. Enzymic activity
was destroyed by the addition of 5 ml. of 10 per cent trichloroacetic
acid. The sources of tissue were male rats fed the +CLO diet given in
Table 1 for 13+ weeks from 11 to 16 days after weaning. The sE animals
weighed 300-363 g. at death, while the +E animals weighed 337-400 g. at
death.
~ean ± standard error of the mean.
Cstatistically significant by the method of paired comparisons
(380) (R_ <. 0. 05).
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ThfilE6
CONVERSION OF CYSTEINE TO SULFATE BY LIVER HOMOGENATES FROM VITAMIN ESUFFICIENT AND -DEFICIENT ADULT FEMALE RATSa

Pair Number

Vitamin E
Deficient
Sufficient
rmoles S04= formed per mg. nitrogen

1

2.67

1.15

2

1.87

1.83

3

2.37

3.27

4

1.96

2.13

5

1.71

2.35

6

2.19

1~73

2.13 ~ 0.14b

2.07 ± 0.29

aThe basic incubation mixture consisted of 0.5 ml. of a 5 per
cent whole liver homogenate in 00067 M. sodium phosphate, buffered at
pH 7.4 and containing 00002 per cent Versene; 125 pmoles of 35scysteine-HC1 in buffer; 100 fmoles of MgCl2; 10 pmoles of ATP in buffer; and sufficient buffer to make 5 ml. The samples were incubated
in air at 37° for 1.5 hours. Enzymic activity was destroyed by the
addition of 5 mlG of 10 per cent trichloroacetic acid. The sources of
tissue were female rats fed the +CLO diets given in Table 1 for 5+
months from 11-12 days after weaning~ The sE animals weighed 196-251
g. at death, while the +E animals weighed 212-262 g.
bMean ± standard error of the mean.

TABLE 7
CONVERSION OF CYSTEINE 'ID SULFATE BY LIVER PREPARATIONS FROM VITAMIN ESUFFICIENT AND -DEFICIENT FEMALE RATSa

Whole Liver
sE

Pair Number

+E

Mitochondria
+E

sE

1moles

0-50 Per Cent
+E
sE

50-70 Per Cent
+E
sE

S04= formed per mg. nitrogen

l

L 70

2.33

0.84

0.91

1. 28

L34

1. 74

L49

2

2.15

2.02

0.70

0,, 91

0.99

I.60

1. 70

5 .. 65

3

1.54

3 .. 13

1.18

1.42

0.79

1. 17

1.08

8~60

LL

1. 67

2.01

1..09

-

1.23

0,,64

0.76

1. 20

1.18

L 76

2.37

0.95b

1. 12

0.92

1.22

1.43

4. 23

: 0. 13

:!: 0.14

'! 0. 18

:!:: 0. 17

:!:: 1. 78

Mean
Standard error
of the mea r.

!

o. 13

!

0.26

:!: 0 .. 11

aThe basic incubation mixture contained 0.5 ml. of a 5 per cent whole liver homogenate, 0.5
mlo of the mitochondrial preparation, 0.5 ml. of the 0-50 per cent fraction, or 1.0 ml. of the 5070 per cent fraction, all made in 0.067 M. sodium phosphate buffered at pH 7.4 and containing 0 .• 005
per cent Versene; 125 pmoles of 35 s-cysteine-HC1 in buffer; 100 pmoles of MgCI2; 10 pmoles of ATP
in buffer; and sufficient buffer to make 5 ml. The samples were incubated in air at 37° for 1.5
hours. Enzymic activity was destroyed by the addition of 5 ml. of IO per cent trichloroacetic acid.
The s:iurces of tissue were the female rats that had been prepped, as described in the text, for 2
weeks prior to weaning and then transferred to the +CLO diet in Table 1. The sE animals weighed
from 133 to 163 g. at death, while the +E animals weighed from 214 to 234 g. at death after being
f.ed t':. e experimental diets for 12+ weeks.
Methods of preparation for the various fractions are
given in the text9
u.Sta tis t ica1 ly sign if ican t by the method of pa ired comparisons (3 80)

Cf<.

0. 05) •

I..O
-....J
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fractions from vitamin E-sufficient liver were compared with those from
vitamin E-deficient liver, but only the mitochondrial fraction displayed
a significantly greater (!.C:..0.05) sulfate production for the supplemented animals.

The 50-70 per cent fraction had the highest activity;

however, the high standard error obtained leaves these data open to
question.
Table 8 reports the ability of liver homogenates from vitamin Esufficient and -deficient male rats fed 18 per cent casein, normal sulfate diets to convert cysteine to sulfate.

Unfortunately, no specific

activity measurements were made on the 35 s-cysteine used, but the results indicate that there is a definite decrease in the ability of the
deficient animals to convert cysteine to sulfate.

Although the results

are not significant, only a few animals were available, and the difference definitely approaches significance (0.l>!>0.05).

Table 9

indicates that there is no sex difference in the ability of vitamin
E-sufficient animals fed normal sulfate diets to convert cysteine to sulfate.
Since the results presented in Tables 4-9 indicated a significant reduction in sulfate production from cysteine by preparations from
vitamin E-deficient male rats and from mitochondria of vitamin E-deficient

0

prepped" female rats, the oxidation of sulfite to sulfate by

sulfite oxidase with ferricyanide (324, 373) was investigated in an
attempt to determine the enzyme system responsible for the decreased
sulfate production.

Twenty-six acetone powder extracts of livers from

10 vitamin E-deficient male rats produced an average change in optical
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TABLE 8
35
35
S-CYSTEINE TO
CONVERSION OF
S-SULFATE BY LIVER HO:MOGENATES FROM
VITAMIN E-SUFFICIENT AND -DEFICIENT MALE RATS FED
NORMAL SULFATE DIETS WITH 18 PER CENT CASEINa

Pair Number

Vitamin E
Sufficient
Deficient
Counts per minute per mg. nitrogen

Per cent
Difference

1

33.7

50.7

-33.5

2

55.8

53.1

+

3

35.6

53.7

-33.8

4

42.5

57.8

-26 .5

5.1

aThe basic incubation mixture contained 0.2 or 0.6 ml. of a 20
per cent whole liver homo~enate in 0.067 M. sodium phosphate, buffered
at pH 7.4; 125 J.Imoles of 5s-cysteine-HC1; 10 pmoles of ATP; 0.18 umoles
of NAD, and sufficient buffer to make 5 ml. The samples were incubated
in air at 37° for 2 hours. Enzymic activity was destroyed by the addition of 5 ml. of 10 per cent trichloroacetic acid. The livers came
from adult animals raised by Brown from weaning (unpublished) and fed
an 18 per cent casein diet (Table 1). O.l>P>0.05 by the method of
paired comparisons (380).
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TABLE 9
CONVERSION OF CYSTEINE TO SULFATE BY LIVER HOMOGENATES FROM VITAMIN ESUFFICIENT ANIMALS FED A NORMAL SULFATE DIETa

Males

Females
ymoles S04= formed per mg. nitrogen

1.47

2.37

1. 67

1. 67

L.27

0.51

1.06

2. 39

0.46

2. 77

1.19

I. 79

2.67b

1.22b

0.74b

2.68b

2o02b

7.06b

l .. 94b

0.51b

7 .. 05b
2. 71 b

2.02 ±: 0.53c

2.02 :t 0.52

aThe basic incubation mixture contained 0.5 ml. of a IO per cent
whole liver homogenate in 0~067 M. sodium phosphate, buffered at pH 7.4;
125 pmoles of 35s-cysteine-HC1; 10 ymoles of ATP; 100 pmoles of MgCl2;
and sufficient buffer to make 5 ml. The samples were incubated at 37°
for 1.5 hours. Enzymic activity was destroyed by the addition of 5 ml.
of 10 per cent trichloroacetic acid. The livers came from animals raised
by Button for 12+ weeks and fed the +E +CLO diet with the Hubbell,
Mendel and Wakeman salt mixture substituted on a weight basis for the
low sulfate salt mixture normally used (Table 1). The males ranged in
weight from 301 to 406 g. and the females from 202 to 258 g. at death.
bo.002 per cent Versene in buffer, 5 per cent homogenates.
cMean ± standard error of the mean.
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density of 0.070

~

00004 per mg. of protein in 10 minutes, while the

extracts from their vitamin E-sufficient littermates produced a change
of 0.074

~

0.004 mg. of protein in 10 minutes.

There was no statis-

tically significant difference in the ability of these acetone powder
extracts to oxidize sulfite to sulfate, nor was there any measurable
sulfite accumulation in either case when denculeated homogenates were
incubated with cysteine.

No measurable cysteinesulfinic acid could be

detected after incubation of the denucleated homogenates with cysteine.
The 2,6-dichlorophenolindophenol assay for sulfite oxidase (324) produced such high blanks that the data were uninterpretable.
Since both commonly proposed pathways for the removal of cysteinesulfinic acid involve enzymes which should require pyridoxal phosphate,
hydroxylamine was employed with the hope that cysteinesulfinic acid
would accumulate and that this accumulation could be measured.

Since

possible destruction of the acid could take place during the isolation
procedure, a determination of the ninhydrin-positive material produced
was employed, as suggested by Sorbo and Ewetz (301).
study are reported in Table 10.

Results of this

There was no statistically significant

difference in the ability of livers from either sex or dietary treatment
to convert cysteine to a ninhydrin-positive material presumed to be
cysteinesulfinic acid, but the high standard error and a disagreement
between duplicate samples would prevent any real conclusions.
In an attempt to identify cysteinesulfinic acid without the chemical degradation possible in the above isolation procedure the incubation
mixture (Table 10) was denatured with 95 per cent ethanol and the material
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TABLE 10
CONVERSION OF CYSTEINE 'ID A NINHYDRIN-POSITIVE "METABOLITE
BY SUPERNATANT FRACTIONS FROM VITAMIN E-SUFFICIENT
AND -DEFICIENT RATSa

Pair
Number

Females
Males
+E
sE
sE
pmoles ninhydrin-positive material per mg. nitrogen

+E

I

0.207

0.254

0.345

0.297

2

0.172

0.139

0.378

0.294

3

1.138

-0.184

0.640

0.230

4

0.530

0.086

0.340

0.348

5

-0.032

0.448

2 .130

-1.010

6

0.173

1.030
0.766 + 0.345

0.031 + 0.261

0.364 + 0.172b

0.295 + 0.170

aThe basic incubation mixture contained 1.0 ml. of the supernatant fraction resulting from centrifuging a 10 per cent whole liver
homogenate prepared in 0.05 M. potassium phosphate, buffered at pH 7.8
and containing 0.005 per cent Versene-Fe-3; 4.5 µmoles of NAD in buffer;
1 ~mole of Fe(NH4 )2(S04)2.6H20; 4 )lmoles of nicotinic acid neutralized
with sodium hydroxide and diluted with buffer; 37 )lmoles of hydroxylamine hydrochloride and 80 Jlmoles of NaOH, mixed before use; 10 Jimoles
of cysteine in buffer; and sufficient buffer to make 5 ml. The samples
were incubated at 37° for 1.5 hours. The enzymic activity was destroyed
by the addition of 0.1 ml. of 1:3 HCl and 1.0 ml. of 10 per cent trichloroacetic acid. Isolation and measurement of the metabolite is detailed in the text. The animals were raised from weaning to 6+ weeks
on the +CLO diet (Table 1). The males ranged in weight at death from
193 to 275 g. and the females from 148 to 179 g.
bMean + standard error of the mean.
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was extracted with chloroform.

While ninhydrin-positive spots could

be seen on paper chromatograms after chromatography of the concentrated
solutions, satisfactory identification of cysteinesulfinic acid could
not be made.

If the chromatograms were developed with alkaline solvents

best for the prevention of streaking of taurine, cysteinesulfinic acid,
and cysteic acid, the spots from the material isolated were streaked.
In an acid solvent poor separation of taurine and cysteinesulfinic acid
standards prevented identification.
Results of oxygen uptake by liver preparations when incubated
with cysteine were inconclusive.

Generally, with the impure fractions,

the enzymic oxygen uptake was small.

With purified fractions denatura-

tion of the enzyme frequently occurred before oxygen uptake could be
measured.

Data from a successful experiment are presented in Table 11.

Sample data suggesting an influence of ATP upon the oxidation
of cysteine to sulfate are presented in Table 12.
This research was hampered by the failure of the active enzyme
solutions to retain activity after freezing or lyophilization or upon
storage at refrigerator temperatures for longer than 24 hours.

For the

partially purified preparations activity could not be retained consistently after storage for 16 hours at refrigerator terrperatures.
The partially purified preparation, in its active form, had about
the same color as a solution of cytochrome c.

If this color had
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TABLE 11
OXYGEN UPTAKE OF PARTIALLY PURIFIED FRACTIONSa

Fraction
20-40 ml. of 0.05 M. eluant

pl. change
20.3
19.1

Same boiled 10 minutes

9.3

80-100 ml. of 0.10 M. eluant

4.8
4.8

Same boiled 10 minutes

3.9

80-100 ml. of 0.15 M. eluant

4.8
4.6

Same boiled 10 minutes

5.6

80-100 ml. of 0.20 M. eluant

4.2
3.9

Same boiled 10 minutes

4.4

80-100 ml. of 0.25 M. eluant

4.6
4.5

Same boiled 10 minutes

2.0

aThe basic incubation mixture contained 0.4 ml. of the indicated
fraction (page 78), 125 µmoles of cysteine-HCl, neutralized in 0.05 M.
potassium phosphate with NaOH, buffered at pH 7.4 and containing 0.005
per cent Versene-Fe-3; 10 umoles of ATP in buffer; 10 µmoles of MgC1 2 ;
0.2 ml. of 1 per cent Versene in buffer, 0.1 ml. of cytochrome c (65
mg. in.25 ml. of buffer); and sufficient buffer to make 3 ml. The
samples were incubated in air at 37.5° for 40 minutes after a 10 minute
equilibration period. Stock colony rats fed the whole wheat-whole milk
stock diet were used as sources of tissue. Fractions were selected
for testing on the basis of visual color intensity.
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TABLE 12
SAMPLE DATA SUGGESTING AN ATP REQUIREMENT FOR THE CONVERSION
OF 35s-cYSTEINE TO 35s-SULFATEa

ml. homogenate

without ATP

with ATP

counts per minute
0.2

50

17

0.6

89

40

96

86

aThe basic incubation mixture contained the indicated quantity
of a 20 per cent whole liver homogenate in 0.067 M. sodium phosphate,
buffered at pH 7.4; 125 µmoles of 3 5s-cysteine-HC1 in buffer; 10 µmoles
of ATP in buffer, where indicated; and sufficient buffer to make 5 ml.
The samples were incubated in air at 37° for 2 hours. Enzymic activity
was destroyed by the addition of 5 ml. of 10 per cent trichloroacetic
acid. A stock colony rat fed the whole wheat-whole milk stock diet
was used as the source of tissue.
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changed to a muddy orange, the preparation was no longer active.
Cytochrome c did not restore activity.

CHAPTER V

DISCUSSION
The results reported in Tables 4-9, together with the in vivo results from this laboratory reported elsewhere (1), indicate that vitamin
E definitely has a role in the oxidation of the sulfur amino acids to
sulfate and may have a role in the direct sulfation of the mucopolysaccharides.

The exact site of the function of vitamin E in the meta-

bolism of the sulfur amino acids could not be determined, both because
of difficulties in methods of analysis and the failure of the assay
techniques to confirm the generally accepted pathway for the oxidation
of the sulfur of cysteine to sulfate.

The pathway studied, that of

oxidation of cysteine to sulfate through cysteinesulf inic acid and
sulfite, could, however, not be discarded on the basis of the experimental results.

The ability of rat liver preparations to react with

the proposed intermediates, together with a general failure to isolate
any of the intermediate reaction products was confirmed.
The need for Fe+ 2 and NADPH (301) in the oxidation of cysteine
to a ninhydrin-positive substan·ce thought to be cysteinesulfinic acid
suggests that cysteine is the true substrate for the reaction, although
why two reducing agents should be needed for an oxidation is interesting, and NADH did not have the same effect as NADPH in increasing
0

cysteinesulf inic acidu formation.

This would suggest that cysteine

desulfhydrase is not the enzyme involved in this reaction.
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Since no
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influence of dietary levels of vitamin E could be found upon the ability
of the enzyme assayed to produce ucysteinesulf inic acid, u the acid may
not be an intermediate in the conversion of cysteine to sulfate by
vitamin E.

The most important indication that the decreased oxidation

of cysteine to sulfate is due to a decreased oxidation of cysteine to
cysteinesulfinic acid is that sulfate added to the incubation mixture
in increasing amounts led to increased production of taurine by the
homogenates from the vitamin E-deficient rats but not by homogenates
from the rats supplemented with the vitamin, while sulfate production
decreased in both groups.*

Since.cysteinesulfinic acid is thought to

be the last common precursor for the formation of both taurine and
sulfate, a defect in the formation of the cysteinesulfinic acid is
indicated.

If sulfate is formed until the sulfate needs of the animal

are met, when no sulfate is present in the diet, then, and only then, is
taurine formed by the liver in normal amounts.

A feedback mechanism

involving taurine and sulfate has been suggested previously (298).
The conversion of methionine to cysteine has been outlined in
Figure 7 and the conversion of cysteine to sulfate through cysteinesulfinic acid in Figure 8.

A slight alteration in the production of cysteine

from methionine is proposed (Figure 9), in which the sulfur atom remains
bound to adenosine in the course of the reaction.

The sulfhydryl group

of cysteine should also be able to react with ATP to form the same
compound (Figure 10).

This type of reaction could prevent the oxidation

*J. T. Smith, Unpublished results.
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of the sulfur amino acid to cysteinee

Then the sulfur of the S-adeno-

sylcysteine could be oxidized to S-adenosylcysteinesulfinic acid,
S-adenosylsulfite, and S-adenosylsulfate by molecular oxygen or some
other electron acceptor.

These compounds have not been reported in

the literature searched, but ease of hydrolysis would prevent identification by many methods.

PAPS and APS are generally considered, at the

present time, to be products of the reaction of sulfate with ATP, and
not intermediates in the oxidation of cysteine to sulfate.
reacts with sulfate to form APS and pyrophosphate.

The ATP

The APS then reacts

with ATP to form PAPS, which is used in sulfation of various compounds,
including the phenols, which are common inhibitors for oxidative
phosphorylation.

There is evidence in microorganisms that PAPS is an

intermediate in the reduction of sulfate to sulfite (382).

Another

possible intermediate in this conversion is x-so 3 -, where Xis thcught
to be a protein thiol group (383).

In the oxidation of sulfite to sul-

fate by ferricyanide by bacteria in the presence of AMP, which produces
APS instead of PAPS for the particular organisms involved, AMP-so 3= is
suggested as a possible, but unlikely intermediate (384).

In animals,

even if ATP were not required for reaction with cysteine, it could serve
to increase sulfate production by binding some of the sulfate formed
during the incubation period and subsequently releasing the sulfate during the analytical procedure.

A requirement for ATP is suggested by the

data in Table 12.
Another interesting factor in the reactivity of ATP with various
anions is that selenate, sulfite, chromate, tungstate, and molybdate
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lead to increasingly active enzymic cleavage by yeast of pyrophosphate
from ATP, which should again influence oxidative phosphorylation.
fate inhibits this liberation (385).

Sul-

The enzyme acts upon ATP to trans-

fer AMP to sulfate to selenate with the formation of APS and traces of
APSe, but forms free AMP from ATP and sulfite, chromate, tungstate, or
molybdate.

The presence of sulfate will prevent the formation of pyro-

phosphate in the reactions where free AMP is liberated (386).

The order

of reactivity in the first paper suggests that very minute traces of
AP-S0 3- could exist.
AP-S0

=

3

The existence of APSe, possible existence of

in microorganisms, the role of selenium in the prevention of

respiratory decline in rats, and the ability of these compounds, plus
sulfite and molybdate, to hydrolyze ATP to pyrophosphate and AMP to
various degrees in yeast suggests several ways in which the metabolism
of these compounds is interrelated.

The decreased absorption and

increased renal excretion of molybdate with increasing dietary levels .
of sulfate fed to animals suffering from molybdate toxicity (239) suggests that sulfate and molybdate are absorbed and excreted by the same
mechanism, but that sulfate is the preferred anion.

Since the process

is one of active transport involving ATP (387), much more stable binding of sulfate to ATP should increase sulfate transport through the
walls of the digestive tract and increase sulfate resorption through
the renal tubules, while decreasing molybdate absorption and increasing
excretion.

Selenate and possibly selenite toxicity should be influenced

in a similar way and selenium de.ficiency in an inverse way.

Appreciable

molybdate in the tissues would interfere with sulfur and copper meta-

llS

bolism by the chemical reactions involved.

Any alteration in ATP forma-

tion or remvoal should affect phosphorylation, active transport, etco
The role of vitamin E could be to enable the introduction of
the high-energy phosphate bonds, thus coupling the oxidation of the
sulfur amino acids to phosphorylation.

An explanation for the failure

of animals fed a vitamin E-deficient high sulfate, low sulfur amino
acid diet to incorporate as much 35 so 4 = after injection as their vitamin
E-sufficient counterparts is that the formation of PAPS or APS from
sulfate or the transfer of the sulfate from PAPS to the acceptor compounds could involve vitamin E or a metabolite.
The ability of both vitamin E and selenium compounds to protect
against lipid peroxidation has been attributed by some to the ability
of both to act as antioxidants.

Vitamin E and selemium may function in

the metabolism of sulfur amino acids in alternative pathways of the
oxidation of these acids.
oxidant.

Cysteine has also been suggested as an anti-

If the role of vitamin E and selenium is only to prevent

lipid peroxidation or to protect labile sulfhydryl groups, it is hard
to visualize why two antioxidants should influence the oxidation of a
thirdo

This is the anamalous situation suggested by the importance of

vitamin E in the oxidation of cysteine to sulfate and the proposed
importance of selenium in this oxidation.

Both vitamin E and vitamin B6

have the ability to relieve some of the symptoms of vitamin E deficiency.

Since vitamin B6 is implicated in transaminase reactions in

the various schemes for the oxidation of the sulfur of cysteine to
sulfate, taurine, and various other intermediates (388), this suggests
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the possibilities that al terr1ative pathways for taurine formation exist
which spare vitamin E for use in the formation of sulfate, that oxidizing cysteinesulfinic

acid to sulfate does not require vitamin B6 ,

or that cysteinesulfinic acid is not on the direct pathway for sulfate
formationo

Some available experimental evidence suggests that vitamin

B6 is not necessary for sulfate formation, but is for the other proposed
deaminations in sulfur amino acid metabolism.
If the role of vitamin E in the prevention of lipid peroxidation
is not simply one of an antioxidant, another function needs to be proposed.

Sulfation of olefins is a common organic chemistry reaction

which is fairly easily reversible.

If such an enzyrnic reaction could

exist in tissue lipids, this would certainly prevent peroxidation of
lipids because the site of attack would be removed.

This sulfation

would also affect cell permeability through alteration in the structure of the lipid in the cell membrane.

Since sulfation, or at least

the formation of sulfate, has been shown to be under the influence of
vitamin E, this could account partially for the increased peroxidizability of tissue lipids from vitamin E-deficient animals.

The changed

membrane structure could also account for the increased susceptibility
of tissues to lysosornal activity.

Since sulfuric acid is commonly

employed in lipid work, the small amount of sulfate bound to the cell
membrane could be masked.
It has been reported that Weil-Malherbe suggested a selective
inhibition of the energy-coupling mechanism (i.-e. oxidative phosphorylation) might account for the increased respiration of dystrophic muscle
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and the increased excretion of creatine.

In the absence of oxidative

phosphorylation creatine would not be phosphorylated, and the unphosphorylated creatine, which the muscle is unable to retain, would be
excreted in greatly increased amounts (165).

A defect in oxidative

phosphorylation would also affect oxidation of Kreb 1 s cycle intermediates.

Influence of thyroxine could be directly on oxidative phosphoryla-

tion.

Again, the thyroid function affects both symptoms of vitamin E

deficiency and sulfur metabolism.
Since fasted animals were not used for the current experiments
and since inanition has been shown on similar diets, (Table 3 and
reference 364), not to be a factor in the slightly decreased size of
many of the vitamin E-deficient animals, comparison between this study
and those of previous workers involving inani tion or fasting has not
been made.

The comparisons made have dealt mainly with rats and rat

liver, since tissue and species differences have indicated alterations
in both the apparent mechanism for the oxidation of the sulfur of the
sulfur amino acids and in the response to the effects of vitamin E
deficiency.
While there is very little experimenta 1 evidence to support many
of the mechanisms suggested in this discussion, there is also little
to contradict the possible existence of the mechanisms.

The precise

location of the defect in in vitro sulfur metabolism in vitamin E
deficiency must await elucidation of the exact pathway for the oxidation of cysteine to sulfate in rat liver and the development and thorough
testing of quantitative analytical procedures for these nethods.

CHAPTER VI
SUMMARY

The conversion of 35 S-cysteine to 35 S-sulfate has been measured
with liver preparations from adult male and female rats.

A statisti-

cally significant decrease in the conversion of cysteine to sulfate
was found in whole liver homogenates from the vitamin E-deficient
male, but not the female, rats fed the low sulfate diets when these
were compared with their littermate controls.

When male and female

rats fed normal sulfate vitamin E-sufficient diets were compared,
there was no statistically significant difference in the conversion
of cysteine to sulfate.

There was also a statistically significant

decrease in the ability of mitochondrial homogenates from the vitamin
E-deficient

11

preppedu female rats to convert cysteine to sulfate when

these were compared with their littermate controls.
No difference could be detected in the ability of acetone powder
extracts from vitamin E-deficient and -sufficient male rats to oxidize
sulfite to sulfate.
Tests were made to determine the presence of cysteinesulfinic
acid and sulfite after incubation of cysteine with denucleated homogenates, but neither substance could be detected.
The conversion of cysteine to a ninhydrin-positive material
thought to be cysteinesulfinic acid by supernatant preparations of
liver from vitamin E-deficient and -sufficient male and female rats was
118
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also studied in the presence of an inhibitor.

There was no detectable

difference in the ability of these preparations to oxidize cysteine.
A mechanism is proposed for the involvement of ATP in the
oxidation of the sulfur group of cysteine to sulfate.
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